# Official Journal C 220/2008

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 220 |
| | |
| English edition | Information and Notices | Volume 5129 August 2008 |

ISSN 1725-2423

Official Journal

of the European Union

C 220

English edition

Information and Notices

Volume 5129 August 2008

---

| Notice No | Contents | page |
| --- | --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
| | Commission |
| 2008/C 220/01 | Authorisation for State aid pursuant to Articles 87 and 88 of the EC Treaty — Cases where the Commission raises no objections | 1 |

Notice No

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

2008/C 220/01

Authorisation for State aid pursuant to Articles 87 and 88 of the EC Treaty — Cases where the Commission raises no objections

1

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
| | Commission |
| 2008/C 220/02 | Euro exchange rates | 4 |
| 2008/C 220/03 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2008 to 31 July 2008(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  ) | 5 |
| 2008/C 220/04 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2008 to 31 July 2008(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  ) | 17 |
| | NOTICES FROM MEMBER STATES |
| 2008/C 220/05 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises (
  1
  ) | 63 |
| 2008/C 220/06 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 68/2001 on the application of Articles 87 and 88 of the EC Treaty to training aid (
  1
  ) | 66 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

2008/C 220/02

Euro exchange rates

4

2008/C 220/03

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2008 to 31 July 2008(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  )

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council

)

5

2008/C 220/04

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2008 to 31 July 2008(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  )

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council

or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council

)

17

NOTICES FROM MEMBER STATES

2008/C 220/05

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises (
  1
  )

1

63

2008/C 220/06

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 68/2001 on the application of Articles 87 and 88 of the EC Treaty to training aid (
  1
  )

1

66

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

| 29.8.2008 | EN | Official Journal of the European Union | C 220/1 |
| --- | --- | --- | --- |

29.8.2008

EN

Official Journal of the European Union

C 220/1

---

Authorisation for State aid pursuant to Articles 87 and 88 of the EC Treaty

Cases where the Commission raises no objections

(2008/C 220/01)

| Date of adoption of the decision | 16.7.2008 |
| --- | --- |
| Aid number | NN 77/05 |
| Member State | France |
| Region | — |
| Title (and/or name of beneficiary) | Réduction du droit d'accise sur certains carburants et combustibles dans le secteur agricole |
| Legal basis | Loi de finances pour 2005, loi de finances rectificative 2004, loi de finances rectificative 2005 et lois suivantes |
| Type of measure | Aid scheme |
| Objective | Aid linked to tax exemptions under Directive 2003/96/EC |
| Form of aid | Reduced tax rates |
| Budget | For example, approximately EUR 142 million in 2006 |
| Intensity | — |
| Duration | 2004 to the present day |
| Economic sectors | Agriculture |
| Name and address of the granting authority | Ministère de l'agriculture et de la pêche |
| 78, rue de Varenne |
| F-75349 Paris 07 SP |

Date of adoption of the decision

16.7.2008

Aid number

NN 77/05

Member State

France

Region

—

Title (and/or name of beneficiary)

Réduction du droit d'accise sur certains carburants et combustibles dans le secteur agricole

Legal basis

Loi de finances pour 2005, loi de finances rectificative 2004, loi de finances rectificative 2005 et lois suivantes

Type of measure

Aid scheme

Objective

Aid linked to tax exemptions under Directive 2003/96/EC

Form of aid

Reduced tax rates

Budget

For example, approximately EUR 142 million in 2006

Intensity

—

Duration

2004 to the present day

Economic sectors

Agriculture

Name and address of the granting authority

Ministère de l'agriculture et de la pêche

78, rue de Varenne

F-75349 Paris 07 SP

| Ministère de l'économie, des finances et de l'industrie |
| --- |
| 135, rue de Bercy |
| F-75572 Paris |

Ministère de l'économie, des finances et de l'industrie

135, rue de Bercy

F-75572 Paris

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/

| Date of adoption of the decision | 17.6.2008 |
| --- | --- |
| Reference number of the aid | N 588/07 |
| Member State | Latvia |
| Region | — |
| Title (and/or name of the beneficiary) | Atbalsts, lai kompensētu zaudējumus, kas radās augļu dārzos bakteriālās iedegas rezultātā |
| Legal basis | Augu aizsardzības likums






  — | 2004. gada 30. marta Ministru kabineta noteikumi Nr. 218 “Augu karantīnas noteikumi” |

Date of adoption of the decision

17.6.2008

Reference number of the aid

N 588/07

Member State

Latvia

Region

—

Title (and/or name of the beneficiary)

Atbalsts, lai kompensētu zaudējumus, kas radās augļu dārzos bakteriālās iedegas rezultātā

Legal basis

Augu aizsardzības likums

—

2004. gada 30. marta Ministru kabineta noteikumi Nr. 218 “Augu karantīnas noteikumi”

Type of measure

Eradication of plant diseases

Objective

Sectoral development

Form of aid

Direct grant and subsidised services

Budget

Overall budget: LVL 350 000 (around EUR 502 585)

Intensity

Up to 100 %

Duration

Until 30.12.2008

Economic sectors

Agricultural sector

Name and address of the granting authority

| Lauku atbalsta dienests |
| --- |
| Republikas laukums 2 |
| LV-1981 Rīga |

Lauku atbalsta dienests

Republikas laukums 2

LV-1981 Rīga

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/

| Date of adoption of the decision | 2.7.2008 |
| --- | --- |
| Reference number of the aid | N 643/07 |
| Member State | Italy |
| Region | Marche |
| Title (and/or name of the beneficiary) | Tutela delle risorse genetiche vegetali |
| Legal basis | Legge regionale 3 giugno 2003 n. 12 «Tutela delle risorse genetiche animali e vegetali del territorio marchigiano». Legge regionale 17 dicembre 2004 n. 28 «Integrazione e modifica della legge regionale 3 giugno 2003 n. 12 — Tutela delle risorse genetiche animali e vegetali del territorio marchigiano» |
| Type of measure | Aid scheme |
| Objective | Agri-environmental commitments aiming at preservation of plant genetic resources under threat of genetic erosion |
| Form of aid | Direct grant |
| Budget | EUR 20 000 per year |
| Intensity | Variable, max. EUR 600/ha |
| Duration | 2008-2013 |
| Economic sectors | Agricultural sector |
| Name and address of the granting authority | Regione Marche |
| Via Tiziano, 44 |
| I-60100 Ancona |

Date of adoption of the decision

2.7.2008

Reference number of the aid

N 643/07

Member State

Italy

Region

Marche

Title (and/or name of the beneficiary)

Tutela delle risorse genetiche vegetali

Legal basis

Legge regionale 3 giugno 2003 n. 12 «Tutela delle risorse genetiche animali e vegetali del territorio marchigiano». Legge regionale 17 dicembre 2004 n. 28 «Integrazione e modifica della legge regionale 3 giugno 2003 n. 12 — Tutela delle risorse genetiche animali e vegetali del territorio marchigiano»

Type of measure

Aid scheme

Objective

Agri-environmental commitments aiming at preservation of plant genetic resources under threat of genetic erosion

Form of aid

Direct grant

Budget

EUR 20 000 per year

Intensity

Variable, max. EUR 600/ha

Duration

2008-2013

Economic sectors

Agricultural sector

Name and address of the granting authority

Regione Marche

Via Tiziano, 44

I-60100 Ancona

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/

| Date of adoption of the decision | 22.7.2008 |
| --- | --- |
| Reference number of the aid | N 182/08 |
| Member State | Federal Republic of Germany |
| Region | Thüringen |
| Title (and/or name of the beneficiary) | Schutz des Waldbodens |
| Legal basis | § 44 LHO |
| Type of measure | Aid scheme |
| Objective | Forest soil protection |
| Form of aid | Grant |
| Budget | EUR 975 000 per year |
| Intensity | 100 % |
| Duration | Until 31.12.2013 |
| Economic sectors | Agriculture |
| Name and address of the granting authority | — |
| Other information | — |

Date of adoption of the decision

22.7.2008

Reference number of the aid

N 182/08

Member State

Federal Republic of Germany

Region

Thüringen

Title (and/or name of the beneficiary)

Schutz des Waldbodens

Legal basis

§ 44 LHO

Type of measure

Aid scheme

Objective

Forest soil protection

Form of aid

Grant

Budget

EUR 975 000 per year

Intensity

100 %

Duration

Until 31.12.2013

Economic sectors

Agriculture

Name and address of the granting authority

—

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

| 29.8.2008 | EN | Official Journal of the European Union | C 220/4 |
| --- | --- | --- | --- |

29.8.2008

EN

Official Journal of the European Union

C 220/4

---

Euro exchange rates (1)

28 August 2008

(2008/C 220/02)

1 euro=

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,4771 |
| JPY | Japanese yen | 161,44 |
| DKK | Danish krone | 7,4584 |
| GBP | Pound sterling | 0,8047 |
| SEK | Swedish krona | 9,438 |
| CHF | Swiss franc | 1,6108 |
| ISK | Iceland króna | 121,81 |
| NOK | Norwegian krone | 7,917 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,703 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 238,56 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7035 |
| PLN | Polish zloty | 3,3498 |
| RON | Romanian leu | 3,5547 |
| SKK | Slovak koruna | 30,307 |
| TRY | Turkish lira | 1,7568 |
| AUD | Australian dollar | 1,7045 |
| CAD | Canadian dollar | 1,5456 |
| HKD | Hong Kong dollar | 11,5322 |
| NZD | New Zealand dollar | 2,0958 |
| SGD | Singapore dollar | 2,0917 |
| KRW | South Korean won | 1 597,85 |
| ZAR | South African rand | 11,3987 |
| CNY | Chinese yuan renminbi | 10,0849 |
| HRK | Croatian kuna | 7,163 |
| IDR | Indonesian rupiah | 13 530,24 |
| MYR | Malaysian ringgit | 5,0037 |
| PHP | Philippine peso | 67,5 |
| RUB | Russian rouble | 36,2855 |
| THB | Thai baht | 50,369 |
| BRL | Brazilian real | 2,3922 |
| MXN | Mexican peso | 14,9844 |

Currency

Exchange rate

USD

US dollar

1,4771

JPY

Japanese yen

161,44

DKK

Danish krone

7,4584

GBP

Pound sterling

0,8047

SEK

Swedish krona

9,438

CHF

Swiss franc

1,6108

ISK

Iceland króna

121,81

NOK

Norwegian krone

7,917

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,703

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

238,56

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7035

PLN

Polish zloty

3,3498

RON

Romanian leu

3,5547

SKK

Slovak koruna

30,307

TRY

Turkish lira

1,7568

AUD

Australian dollar

1,7045

CAD

Canadian dollar

1,5456

HKD

Hong Kong dollar

11,5322

NZD

New Zealand dollar

2,0958

SGD

Singapore dollar

2,0917

KRW

South Korean won

1 597,85

ZAR

South African rand

11,3987

CNY

Chinese yuan renminbi

10,0849

HRK

Croatian kuna

7,163

IDR

Indonesian rupiah

13 530,24

MYR

Malaysian ringgit

5,0037

PHP

Philippine peso

67,5

RUB

Russian rouble

36,2855

THB

Thai baht

50,369

BRL

Brazilian real

2,3922

MXN

Mexican peso

14,9844

---

(1)

Source: reference exchange rate published by the ECB.

---

| 29.8.2008 | EN | Official Journal of the European Union | C 220/5 |
| --- | --- | --- | --- |

29.8.2008

EN

Official Journal of the European Union

C 220/5

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2008 to 31 July 2008

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
   (1)
  )

(2008/C 220/03)

—   Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN
  (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code
  (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 2.7.2008 | RELISTOR | Methylnaltrexone bromide | Wyeth Europa Limited |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire SL6 0PH |
| United Kingdom |

Date of the decision

Name of the medicinal product

INN

(International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code

(Anatomical Therapeutic Chemical Code)

Date of notification

2.7.2008

RELISTOR

Methylnaltrexone bromide

Wyeth Europa Limited

Huntercombe Lane South

Taplow

Maidenhead

Berkshire SL6 0PH

United Kingdom

EU/1/08/463/001-003

Solution for injection

(Non applicable)

4.7.2008

3.7.2008

Trevaclyn

Nicotinic acid/laropiprant

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/08/458/001-011

Modified-release tablet

C10AD52

7.7.2008

3.7.2008

Pelzont

Nicotinic acid/laropiprant

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/08/460/001-011

Modified-release tablet

C10AD52

7.7.2008

3.7.2008

Tredaptive

Nicotinic acid/laropiprant

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/08/459/001-011

Modified-release tablet

C10AD52

7.7.2008

9.7.2008

Latixa

Ranolazine

| CV Therapeutics Europe Limited |
| --- |
| 15 Meadway Court |
| Rutherford Close |
| Stevenage |
| Hertfordshire SG1 2EF |
| United Kingdom |

CV Therapeutics Europe Limited

15 Meadway Court

Rutherford Close

Stevenage

Hertfordshire SG1 2EF

United Kingdom

EU/1/08/462/001-006

Prolonged release tablet

C01EB18

14.7.2008

11.7.2008

Firazyr

Icatibant

| Jerini AG |
| --- |
| Invalidenstr. 130 |
| D-10115 Berlin |

Jerini AG

Invalidenstr. 130

D-10115 Berlin

EU/1/08/461/001

Solution for injection

(Non applicable)

15.7.2008

16.7.2008

Clopidogrel BMS

Clopidogrel

| BRISTOL MYERS SQUIBB PHARMA EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge UB8 1DH |
| United Kingdom |

BRISTOL MYERS SQUIBB PHARMA EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge UB8 1DH

United Kingdom

EU/1/08/464/001-017

Film-coated tablet

B01AC04

18.7.2008

16.7.2008

Clopidogrel Winthrop

Clopidogrel

| Sanofi Pharma Bristol-Myers Squibb SNC |
| --- |
| 174, avenue de France |
| F-75013 Paris |

Sanofi Pharma Bristol-Myers Squibb SNC

174, avenue de France

F-75013 Paris

EU/1/08/465/001-017

Film-coated tablet

B01AC04

18.7.2008

16.7.2008

Janumet

Sitagliptin/metformin hydrochloride

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United-Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United-Kingdom

EU/1/08/455/001-014

Film-coated tablet

A10BD07

18.7.2008

16.7.2008

Efficib

Sitagliptin/metformin hydrochloride

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/08/457/001-014

Film-coated tablet

A10BD07

18.7.2008

16.7.2008

Velmetia

Sitagliptin/metformin hydrochloride

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/08/456/001-014

Film-coated tablet

A10BD07

18.7.2008

25.7.2008

Bridion

Sugammadex

| N.V. Organon |
| --- |
| Kloosterstraat 6 |
| 5349 AB Oss |
| Nederland |

N.V. Organon

Kloosterstraat 6

5349 AB Oss

Nederland

EU/1/08/466/001-002

Solution for injection

V03AB35

29.7.2008

25.7.2008

Doribax

Doripenem

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg, 30 |
| B-2340 Beerse |

Janssen-Cilag International NV

Turnhoutseweg, 30

B-2340 Beerse

EU/1/08/467/001

Powder for solution for infusion

J01DH04

29.7.2008

—   Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 2.7.2008 | PritorPlus | Bayer HealthCare AG |
| D-51368 Leverkusen |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

2.7.2008

PritorPlus

Bayer HealthCare AG

D-51368 Leverkusen

EU/1/02/215/001-021

7.7.2008

2.7.2008

Epivir

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/96/015/001-005

4.7.2008

2.7.2008

Pritor

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

EU/1/98/089/001-022

4.7.2008

2.7.2008

INCRELEX

| Tercica Europe Limited |
| --- |
| Riverside One |
| Sir John Rogerson's Quay |
| Dublin 2 |
| Ireland |

Tercica Europe Limited

Riverside One

Sir John Rogerson's Quay

Dublin 2

Ireland

EU/1/07/402/001

4.7.2008

3.7.2008

Kinzalkomb

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

EU/1/02/214/001-015

7.7.2008

3.7.2008

Micardis

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/98/090/001-020

7.7.2008

3.7.2008

Aranesp

| Amgen Europe B.V. |
| --- |
| Minervum 7061 |
| 4817 ZK Breda |
| Nederland |

Amgen Europe B.V.

Minervum 7061

4817 ZK Breda

Nederland

EU/1/01/185/001-073

7.7.2008

3.7.2008

Nespo

| Dompé Biotec S.p.A. |
| --- |
| Via San Martino, 12 |
| I-20122 Milano |

Dompé Biotec S.p.A.

Via San Martino, 12

I-20122 Milano

EU/1/01/184/001-073

7.7.2008

4.7.2008

Mabthera

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/98/067/001-002

8.7.2008

4.7.2008

Rotarix

| GlaxoSmithKline Biologicals s.a |
| --- |
| rue de l'Institut, 89 |
| B-1330 Rixensart |

GlaxoSmithKline Biologicals s.a

rue de l'Institut, 89

B-1330 Rixensart

EU/1/05/330/001-004

8.7.2008

4.7.2008

MabCampath

| Genzyme Europe B.V. |
| --- |
| Gooimeer 10 |
| 1411 DD Naarden |
| Nederland |

Genzyme Europe B.V.

Gooimeer 10

1411 DD Naarden

Nederland

EU/1/01/193/001-002

8.7.2008

4.7.2008

Prezista

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg, 30 |
| B-2340 Beerse |

Janssen-Cilag International NV

Turnhoutseweg, 30

B-2340 Beerse

EU/1/06/380/001

8.7.2008

4.7.2008

MicardisPlus

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/02/213/001-023

8.7.2008

4.7.2008

Kinzalmono

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

EU/1/98/091/001-014

8.7.2008

4.7.2008

Zometa

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/01/176/001-006

8.7.2008

7.7.2008

TOVIAZ

| Pfizer Limited |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent CT13 9NJ |
| United Kingdom |

Pfizer Limited

Ramsgate Road

Sandwich

Kent CT13 9NJ

United Kingdom

EU/1/07/386/001-012

9.7.2008

7.7.2008

Vasovist

| Bayer Schering Pharma AG |
| --- |
| D-13342 Berlin |

Bayer Schering Pharma AG

D-13342 Berlin

EU/1/05/313/001-009

9.7.2008

7.7.2008

Kepivance

| Amgen Europe B.V. |
| --- |
| Minervum 7061 |
| 4817 ZK Breda |
| Nederland |

Amgen Europe B.V.

Minervum 7061

4817 ZK Breda

Nederland

EU/1/05/314/001

9.7.2008

7.7.2008

Telzir

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/04/282/001-002

9.7.2008

7.7.2008

Invirase

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/96/026/001-002

9.7.2008

7.7.2008

Tamiflu

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/02/222/001-004

9.7.2008

7.7.2008

Siklos

| Addmedica |
| --- |
| 84, rue d'Amsterdam |
| F-75009 Paris |

Addmedica

84, rue d'Amsterdam

F-75009 Paris

EU/1/07/397/001

9.7.2008

7.7.2008

Enbrel

| Wyeth Europa Limited |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire SL6 0PH |
| United Kingdom |

Wyeth Europa Limited

Huntercombe Lane South

Taplow

Maidenhead

Berkshire SL6 0PH

United Kingdom

EU/1/99/126/001-018

9.7.2008

7.7.2008

Aldara

| Meda AB |
| --- |
| Pipers väg 2A |
| S-170 73 Solna |

Meda AB

Pipers väg 2A

S-170 73 Solna

EU/1/98/080/001

9.7.2008

7.7.2008

Aptivus

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/05/315/001

9.7.2008

8.7.2008

Zalasta

| KRKA, d.d. |
| --- |
| Šmarješka cesta 6 |
| SLO-8501 Novo mesto |

KRKA, d.d.

Šmarješka cesta 6

SLO-8501 Novo mesto

EU/1/07/415/001-056

10.7.2008

8.7.2008

Binocrit

| Sandoz GmbH |
| --- |
| Biochemiestraße 10 |
| A-6250 Kundl |

Sandoz GmbH

Biochemiestraße 10

A-6250 Kundl

EU/1/07/410/001-020

10.7.2008

8.7.2008

Fuzeon

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/03/252/001-003

10.7.2008

8.7.2008

Epoetin alfa Hexal

| HEXAL Biotech Forschungs GmbH |
| --- |
| Industriestraße 25 |
| D-83607 Holzkirchen |

HEXAL Biotech Forschungs GmbH

Industriestraße 25

D-83607 Holzkirchen

EU/1/07/411/001-020

10.7.2008

8.7.2008

Busilvex

| Pierre Fabre Médicament |
| --- |
| 45, Place Abel Gance |
| F-92654 Boulogne Billancourt Cedex |

Pierre Fabre Médicament

45, Place Abel Gance

F-92654 Boulogne Billancourt Cedex

EU/1/03/254/002

10.7.2008

9.7.2008

Rasilez

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/07/405/001-020

11.7.2008

9.7.2008

Exubera

| Pfizer Ltd |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent CT13 9NJ |
| United Kingdom |

Pfizer Ltd

Ramsgate Road

Sandwich

Kent CT13 9NJ

United Kingdom

EU/1/05/327/001-018

11.7.2008

9.7.2008

Cholestagel

| Genzyme Europe B.V. |
| --- |
| Gooimeer 10 |
| 1411 DD Naarden |
| Nederland |

Genzyme Europe B.V.

Gooimeer 10

1411 DD Naarden

Nederland

EU/1/03/268/001-003

11.7.2008

9.7.2008

Circadin

| RAD Neurim Pharmaceuticals EEC Limited |
| --- |
| 6 Fortuna Court |
| Calleva Park |
| Aldermaston |
| Berkshire RG7 8UB |
| United Kingdom |

RAD Neurim Pharmaceuticals EEC Limited

6 Fortuna Court

Calleva Park

Aldermaston

Berkshire RG7 8UB

United Kingdom

EU/1/07/392/001-002

11.7.2008

9.7.2008

Pedea

| Orphan Europe SARL |
| --- |
| Immeuble Le Wilson |
| 70, avenue du Général de Gaulle |
| F-92800 Puteaux |

Orphan Europe SARL

Immeuble Le Wilson

70, avenue du Général de Gaulle

F-92800 Puteaux

EU/1/04/284/001

11.7.2008

9.7.2008

Sprimeo

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/07/407/001-020

11.7.2008

9.7.2008

Enviage

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/07/406/001-020

11.7.2008

9.7.2008

Tekturna

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/07/408/001-020

11.7.2008

9.7.2008

Riprazo

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/07/409/001-020

11.7.2008

10.7.2008

Bonviva

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/03/265/003-004

14.7.2008

10.7.2008

Bondenza

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/03/266/003-004

14.7.2008

10.7.2008

Optaflu

| Novartis Vaccines and Diagnostics GmbH & Co. KG |
| --- |
| Emil-von-Behring-Straße 76 |
| D-35041 Marburg |

Novartis Vaccines and Diagnostics GmbH & Co. KG

Emil-von-Behring-Straße 76

D-35041 Marburg

EU/1/07/394/001-009

14.7.2008

10.7.2008

ViraferonPeg

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73/Stallestraat, 73 |
| B-1180 Bruxelles/B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73/Stallestraat, 73

B-1180 Bruxelles/B-1180 Brussel

EU/1/00/132/001-050

14.7.2008

10.7.2008

Remicade

| Centocor B.V. |
| --- |
| Einsteinweg 101 |
| 2333 CB Leiden |
| Nederland |

Centocor B.V.

Einsteinweg 101

2333 CB Leiden

Nederland

EU/1/99/116/001-003

14.7.2008

10.7.2008

Silgard

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/06/358/001-021

14.7.2008

10.7.2008

PegIntron

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73/Stallestraat, 73 |
| B-1180 Bruxelles/B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73/Stallestraat, 73

B-1180 Bruxelles/B-1180 Brussel

EU/1/00/131/001-050

14.7.2008

10.7.2008

Gardasil

| Sanofi Pasteur MSD, SNC |
| --- |
| 8, rue Jonas Salk |
| F-69007 Lyon |

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk

F-69007 Lyon

EU/1/06/357/001-021

15.7.2008

11.7.2008

Sustiva

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge UB8 1DH |
| United Kingdom |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge UB8 1DH

United Kingdom

EU/1/99/110/001-009

15.7.2008

11.7.2008

Stocrin

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/99/111/001-011

15.7.2008

11.7.2008

Liprolog

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/01/195/022-027

15.7.2008

17.7.2008

Zimulti

| Sanofi-Aventis |
| --- |
| 174, avenue de France |
| F-75013 Paris |

Sanofi-Aventis

174, avenue de France

F-75013 Paris

EU/1/06/345/001-011

23.7.2008

17.7.2008

Humira

| Abbott Laboratories Ltd |
| --- |
| Queenborough |
| Kent ME11 5EL |
| United Kingdom |

Abbott Laboratories Ltd

Queenborough

Kent ME11 5EL

United Kingdom

EU/1/03/256/001-010

23.7.2008

17.7.2008

Erbitux

| Merck KGaA |
| --- |
| Frankfurter Straße 250 |
| D-64271 Darmstadt |

Merck KGaA

Frankfurter Straße 250

D-64271 Darmstadt

EU/1/04/281/001-005

23.7.2008

17.7.2008

ACOMPLIA

| Sanofi-Aventis |
| --- |
| 174, avenue de France |
| F-75013 Paris |

Sanofi-Aventis

174, avenue de France

F-75013 Paris

EU/1/06/344/001-011

23.7.2008

22.7.2008

Silapo

| STADA Arzneimittel AG |
| --- |
| Stadastraße 2-18 |
| D-61118 Bad Vilbel |

STADA Arzneimittel AG

Stadastraße 2-18

D-61118 Bad Vilbel

EU/1/07/432/001-022

24.7.2008

22.7.2008

Sprycel

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge UB8 1DH |
| United Kingdom |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge UB8 1DH

United Kingdom

EU/1/06/363/001-009

24.7.2008

22.7.2008

CUBICIN

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/05/328/001-002

24.7.2008

23.7.2008

Prandin

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/00/162/003-005

EU/1/00/162/009-011

EU/1/00/162/015-017

EU/1/00/162/019-021

25.7.2008

23.7.2008

Exjade

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/06/356/001-006

25.7.2008

23.7.2008

NovoNorm

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/98/076/004-006

EU/1/98/076/011-013

EU/1/98/076/018-020

EU/1/98/076/022-024

25.7.2008

23.7.2008

Quadramet

| CIS bio international |
| --- |
| Boîte Postale 32 |
| F-91192 Gif-sur-Yvette |

CIS bio international

Boîte Postale 32

F-91192 Gif-sur-Yvette

EU/1/97/057/001

25.7.2008

24.7.2008

Keppra

| UCB Pharma S.A. |
| --- |
| Allée de la Recherche, 60/Researchdreef, 60 |
| B-1070 Bruxelles/B-1070 Brussel |

UCB Pharma S.A.

Allée de la Recherche, 60/Researchdreef, 60

B-1070 Bruxelles/B-1070 Brussel

EU/1/00/146/030

28.7.2008

25.7.2008

Keppra

| UCB Pharma S.A. |
| --- |
| Allée de la Recherche, 60/Researchdreef, 60 |
| B-1070 Bruxelles/B-1070 Brussel |

UCB Pharma S.A.

Allée de la Recherche, 60/Researchdreef, 60

B-1070 Bruxelles/B-1070 Brussel

EU/1/00/146/001-030

29.7.2008

25.7.2008

REYATAZ

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge UB8 1DH |
| United Kingdom |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge UB8 1DH

United Kingdom

EU/1/03/267/001-009

29.7.2008

25.7.2008

Trisenox

| Cephalon Europe |
| --- |
| 5, rue Charles Martigny |
| F-94700 Maisons Alfort Cedex |

Cephalon Europe

5, rue Charles Martigny

F-94700 Maisons Alfort Cedex

EU/1/02/204/001

29.7.2008

25.7.2008

Myfenax

| Teva Pharma B.V. |
| --- |
| Computerweg 10 |
| DR Utrecht 3542 |
| Nederland |

Teva Pharma B.V.

Computerweg 10

DR Utrecht 3542

Nederland

EU/1/07/438/001-004

29.7.2008

25.7.2008

Valtropin

| BioPartners GmbH |
| --- |
| Eisenstraße 3 |
| D-65428 Rüsselsheim |

BioPartners GmbH

Eisenstraße 3

D-65428 Rüsselsheim

EU/1/06/335/001

—

25.7.2008

Zeffix

| Glaxo Group Limited |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Limited

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/99/114/001-003

29.7.2008

25.7.2008

Mycophenolate mofetil Teva

| Teva Pharma B.V. |
| --- |
| Computerweg 10 |
| DR Utrecht 3542 |
| Nederland |

Teva Pharma B.V.

Computerweg 10

DR Utrecht 3542

Nederland

EU/1/07/439/001-004

29.7.2008

28.7.2008

Cymbalta

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/04/296/001-009

30.7.2008

28.7.2008

Zyprexa

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/96/022/002

EU/1/96/022/004

EU/1/96/022/006

EU/1/96/022/008-012

EU/1/96/022/014

EU/1/96/022/016-017

EU/1/96/022/019-034

30.7.2008

28.7.2008

NovoMix

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/00/142/004-005

EU/1/00/142/009-022

30.7.2008

28.7.2008

Xeristar

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/04/297/001-008

30.7.2008

28.7.2008

Zostavax

| Sanofi Pasteur MSD SNC |
| --- |
| 8, rue Jonas Salk |
| F-69007 Lyon |

Sanofi Pasteur MSD SNC

8, rue Jonas Salk

F-69007 Lyon

EU/1/06/341/001-013

30.7.2008

28.7.2008

Zyprexa Velotab

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/99/125/001-016

30.7.2008

28.7.2008

Prezista

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg, 30 |
| B-2340 Beerse |

Janssen-Cilag International NV

Turnhoutseweg, 30

B-2340 Beerse

EU/1/06/380/001

30.7.2008

28.7.2008

Vivanza

| Bayer AG |
| --- |
| D-51368 Leverkusen |

Bayer AG

D-51368 Leverkusen

EU/1/03/249/001-012

30.7.2008

28.7.2008

Levitra

| Bayer AG |
| --- |
| D-51368 Leverkusen |

Bayer AG

D-51368 Leverkusen

EU/1/03/248/001-012

30.7.2008

28.7.2008

Ventavis

| Bayer Schering Pharma AG |
| --- |
| Müllerstraße 170-178 |
| D-13342 Berlin |

Bayer Schering Pharma AG

Müllerstraße 170-178

D-13342 Berlin

EU/1/03/255/001-006

30.7.2008

28.7.2008

Viracept

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/97/054/001

EU/1/97/054/004-005

30.7.2008

29.7.2008

Tracleer

| Actelion Registration Ltd |
| --- |
| BSI Building 13th Floor |
| 389 Chiswick High Road |
| London W4 4AL |
| United Kingdom |

Actelion Registration Ltd

BSI Building 13th Floor

389 Chiswick High Road

London W4 4AL

United Kingdom

EU/1/02/220/001-005

31.7.2008

29.7.2008

Remicade

| Centocor B.V. |
| --- |
| Einsteinweg 101 |
| 2333 CB Leiden |
| Nederland |

Centocor B.V.

Einsteinweg 101

2333 CB Leiden

Nederland

EU/1/99/116/001-003

31.7.2008

29.7.2008

Velcade

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg, 30 |
| B-2340 Beerse |

Janssen-Cilag International NV

Turnhoutseweg, 30

B-2340 Beerse

EU/1/04/274/001-002

31.7.2008

29.7.2008

Angiox

| The Medicines Company UK Ltd |
| --- |
| Suite B |
| Park House |
| 11 Milton Park |
| Abingdon |
| Oxfordshire OX14 4RS |
| United Kingdom |

The Medicines Company UK Ltd

Suite B

Park House

11 Milton Park

Abingdon

Oxfordshire OX14 4RS

United Kingdom

EU/1/04/289/001-002

31.7.2008

29.7.2008

INCRELEX

| Tercica Europe Limited |
| --- |
| Riverside One |
| Sir John Rogerson's Quay |
| Dublin 2 |
| Ireland |

Tercica Europe Limited

Riverside One

Sir John Rogerson's Quay

Dublin 2

Ireland

EU/1/07/402/001

31.7.2008

29.7.2008

Naglazyme

| BioMarin Europe Limited |
| --- |
| Axtell House |
| 23-24 Warwick Street |
| London W1B 5NQ |
| United Kingdom |

BioMarin Europe Limited

Axtell House

23-24 Warwick Street

London W1B 5NQ

United Kingdom

EU/1/05/324/001-002

31.7.2008

29.7.2008

Circadin

| RAD Neurim Pharmaceuticals EEC Limited |
| --- |
| 6 Fortuna Court |
| Calleva Park |
| Aldermaston |
| Berkshire RG7 8UB |
| United Kingdom |

RAD Neurim Pharmaceuticals EEC Limited

6 Fortuna Court

Calleva Park

Aldermaston

Berkshire RG7 8UB

United Kingdom

EU/1/07/392/001-002

31.7.2008

29.7.2008

Telzir

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/04/282/001-002

31.7.2008

29.7.2008

Pylobactell

| Torbet Laboratories Limited |
| --- |
| Unit 14D |
| Wendover Road |
| Rackheath Industrial Estate |
| Norwich |
| Norfolk NR13 6LH |
| United Kingdom |

Torbet Laboratories Limited

Unit 14D

Wendover Road

Rackheath Industrial Estate

Norwich

Norfolk NR13 6LH

United Kingdom

EU/1/98/064/001

1.8.2008

31.7.2008

Revlimid

| Celgene Europe Limited |
| --- |
| Morgan House |
| Madeira Walk |
| Windsor |
| Berkshire SL4 1EP |
| United Kingdom |

Celgene Europe Limited

Morgan House

Madeira Walk

Windsor

Berkshire SL4 1EP

United Kingdom

EU/1/07/391/001-004

5.8.2008

31.7.2008

DuoTrav

| Alcon Laboratories (UK) Ltd |
| --- |
| Pentagon Park |
| Boundary Way |
| Hemel Hempstead |
| Herts HP2 7UD |
| United Kingdom |

Alcon Laboratories (UK) Ltd

Pentagon Park

Boundary Way

Hemel Hempstead

Herts HP2 7UD

United Kingdom

EU/1/06/338/001-003

5.8.2008

31.7.2008

ADROVANCE

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/06/364/001-009

5.8.2008

—   Issuing of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN
  (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code
  (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 8.7.2008 | Reconcile | Fluoxétine | Eli Lilly and Company Ltd |
| Priestley Road |
| Basingstoke |
| Hampshire RG24 9NL |
| United Kingdom |

Date of the decision

Name of the medicinal product

INN

(International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code

(Anatomical Therapeutic Chemical Code)

Date of notification

8.7.2008

Reconcile

Fluoxétine

Eli Lilly and Company Ltd

Priestley Road

Basingstoke

Hampshire RG24 9NL

United Kingdom

EU/2/08/080/001-004

Chewable tablets

QN06AB03

16.7.2008

24.7.2008

ZACTRAN

Gamithromycine

| MERIAL |
| --- |
| 29, avenue Tony Garnier |
| F-69007 Lyon |

MERIAL

29, avenue Tony Garnier

F-69007 Lyon

EU/2/08/082/001-003

Solution for injection

QJ01FA95

28.7.2008

—   Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 11.7.2008 | Equilis Te | Intervet International B.V. |
| Wim de Körverstraat 35 |
| 5831 AN Boxmeer |
| Nederland |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

11.7.2008

Equilis Te

Intervet International B.V.

Wim de Körverstraat 35

5831 AN Boxmeer

Nederland

EU/2/05/055/001-002

15.7.2008

11.7.2008

Equilis Prequenza Te

| Intervet International B.V. |
| --- |
| Wim de Körverstraat 35 |
| 5831 AN Boxmeer |
| Nederland |

Intervet International B.V.

Wim de Körverstraat 35

5831 AN Boxmeer

Nederland

EU/2/05/057/001-004

15.7.2008

11.7.2008

ProMeris

| Fort Dodge Animal Health Holland |
| --- |
| C.J. van Houtenlaan 36 |
| 1381 CP Weesp |
| Nederland |

Fort Dodge Animal Health Holland

C.J. van Houtenlaan 36

1381 CP Weesp

Nederland

EU/2/06/064/001-004

15.7.2008

31.7.2008

Poulvac FluFend H5N3 RG

| Fort Dodge Animal Health Ltd |
| --- |
| Flanders Road |
| Hedge End |
| Southampton SO30 4QH |
| United Kingdom |

Fort Dodge Animal Health Ltd

Flanders Road

Hedge End

Southampton SO30 4QH

United Kingdom

EU/2/06/060/001-002

5.8.2008

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| The European Medicines Agency |
| --- |
| 7, Westferry Circus |
| Canary Wharf |
| London E14 4HB |
| United Kingdom |

The European Medicines Agency

7, Westferry Circus

Canary Wharf

London E14 4HB

United Kingdom

---

(1)  OJ L 136, 30.4.2004, p. 1.

---

| 29.8.2008 | EN | Official Journal of the European Union | C 220/17 |
| --- | --- | --- | --- |

29.8.2008

EN

Official Journal of the European Union

C 220/17

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2008 to 31 July 2008

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
   (1)
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
   (2)
  )

(2008/C 220/04)

—   Issuing, maintenance or modification of a national marketing authorisation

| Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- |
| 9.7.2008 | Latixa | CV Therapeutics Europe Limited |
| 15 Meadway Court |
| Rutherford Close |
| Stevenage |
| Hertfordshire SG1 2EF |
| United Kingdom |

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorization

Member State concerned

Date of notification

9.7.2008

Latixa

CV Therapeutics Europe Limited

15 Meadway Court

Rutherford Close

Stevenage

Hertfordshire SG1 2EF

United Kingdom

This Decision is addressed to the Member States

10.7.2008

11.7.2008

Alvesco

See Annex I

See Annex I

14.7.2008

11.7.2008

Singulair

See Annex II

See Annex II

14.7.2008

14.7.2008

Octegra

See Annex III

See Annex III

15.7.2008

14.7.2008

Actira

See Annex IV

See Annex IV

16.7.2008

14.7.2008

Avalox

See Annex V

See Annex V

16.7.2008

22.7.2008

Oracea

See Annex VI

See Annex VI

23.7.2008

23.7.2008

Lamictal

See Annex VII

See Annex VII

28.7.2008

31.7.2008

Revlimid

| Celgene Europe Limited |
| --- |
| Morgan House |
| Madeira Walk |
| Windsor |
| Berkshire SL4 1EP |
| United Kingdom |

Celgene Europe Limited

Morgan House

Madeira Walk

Windsor

Berkshire SL4 1EP

United Kingdom

This Decision is addressed to the Member States

4.8.2008

---

(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.

---

ANNEX I

LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANT(S), MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Applicant | Invented Name | Strength | Pharmaceutical Form | Route of administration |
| --- | --- | --- | --- | --- | --- | --- |
| Austria | | Nycomed Pharma GmbH |
| EUROPLAZA |
| Gebäude F |
| Technologiestraße 5 |
| A-1120 Wien |

Member State

Marketing Authorisation Holder

Applicant

Invented Name

Strength

Pharmaceutical Form

Route of administration

Austria

Nycomed Pharma GmbH

EUROPLAZA

Gebäude F

Technologiestraße 5

A-1120 Wien

Alvesco 40 Mikrogramm Dosieraerosol

40 μg

Pressurised inhalation, solution

Inhalation use

Austria

| Nycomed Pharma GmbH |
| --- |
| EUROPLAZA |
| Gebäude F |
| Technologiestraße 5 |
| A-1120 Wien |

Nycomed Pharma GmbH

EUROPLAZA

Gebäude F

Technologiestraße 5

A-1120 Wien

Alvesco 80 Mikrogramm Dosieraerosol

80 μg

Pressurised inhalation, solution

Inhalation use

Austria

| Nycomed Pharma GmbH |
| --- |
| EUROPLAZA |
| Gebäude F |
| Technologiestraße 5 |
| A-1120 Wien |

Nycomed Pharma GmbH

EUROPLAZA

Gebäude F

Technologiestraße 5

A-1120 Wien

Alvesco 160 Mikrogramm Dosieraerosol

160 μg

Pressurised inhalation, solution

Inhalation use

Austria

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Amavio 40 Mikrogramm Dosieraerosol

40 μg

Pressurised inhalation, solution

Inhalation use

Austria

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Amavio 80 Mikrogramm Dosieraerosol

80 μg

Pressurised inhalation, solution

Inhalation use

Austria

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Amavio 160 Mikrogramm Dosieraerosol

40 μg

Pressurised inhalation, solution

Inhalation use

Belgium

| Nycomed Belgium s.c.a./c.v.a. |
| --- |
| Gentsesteenweg 615 |
| B-1080 Brussels |

Nycomed Belgium s.c.a./c.v.a.

Gentsesteenweg 615

B-1080 Brussels

Alvesco 40 microgram, aërosol, oplossing

40 μg

Pressurised inhalation, solution

Inhalation use

Belgium

| Nycomed Belgium s.c.a./c.v.a. |
| --- |
| Gentsesteenweg 615 |
| B-1080 Brussels |

Nycomed Belgium s.c.a./c.v.a.

Gentsesteenweg 615

B-1080 Brussels

Alvesco 80 microgram, aërosol, oplossing

80 μg

Pressurised inhalation, solution

Inhalation use

Belgium

| Nycomed Belgium s.c.a./c.v.a. |
| --- |
| Gentsesteenweg 615 |
| B-1080 Brussels |

Nycomed Belgium s.c.a./c.v.a.

Gentsesteenweg 615

B-1080 Brussels

Alvesco 160 microgram, aërosol, oplossing

160 μg

Pressurised inhalation, solution

Inhalation use

Bulgaria

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 Inhaler

40 μg

Pressurised inhalation, solution

Inhalation use

Bulgaria

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Inhaler

80 μg

Pressurised inhalation, solution

Inhalation use

Bulgaria

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Inhaler

160 μg

Pressurised inhalation, solution

Inhalation use

Cyprus

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 micrograms Inhaler

40 μg

Pressurised inhalation, solution

Inhalation use

Cyprus

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 micrograms Inhaler

80 μg

Pressurised inhalation, solution

Inhalation use

Cyprus

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 micrograms Inhaler

160 μg

Pressurised inhalation, solution

Inhalation use

Czech Republic

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Inhaler

80 μg

Pressurised inhalation, solution

Inhalation use

Czech Republic

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Inhaler

160 μg

Pressurised inhalation, solution

Inhalation use

Denmark

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 micrograms pressurised inhalation, solution

40 μg

Pressurised inhalation, solution

Inhalation use

Denmark

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 micrograms pressurised inhalation, solution

80 μg

Pressurised inhalation, solution

Inhalation use

Denmark

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 micrograms pressurised inhalation, solution

160 μg

Pressurised inhalation, solution

Inhalation use

Estonia

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 micrograms pressurised inhalation, solution

40 μg

Pressurised inhalation, solution

Inhalation use

Estonia

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 micrograms pressurised inhalation, solution

80 μg

Pressurised inhalation, solution

Inhalation use

Estonia

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 micrograms pressurised inhalation, solution

160 μg

Pressurised inhalation, solution

Inhalation use

Finland

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 micrograms pressurised inhalation, solution

40 μg

Pressurised inhalation, solution

Inhalation use

Finland

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 micrograms pressurised inhalation, solution

80 μg

Pressurised inhalation, solution

Inhalation use

Finland

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 micrograms pressurised inhalation, solution

160 μg

Pressurised inhalation, solution

Inhalation use

France

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 microgrammes, dose solution pour inhalation en flacon pressurisé

40 μg

Pressurised inhalation, solution

Inhalation use

France

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 microgrammes, dose solution pour inhalation en flacon pressurisé

80 μg

Pressurised inhalation, solution

Inhalation use

France

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 microgrammes, dose solution pour inhalation en flacon pressurisé

160 μg

Pressurised inhalation, solution

Inhalation use

Germany

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 Mikrogramm Druckgasinhalation, Lösung

40 μg

Pressurised inhalation, solution

Inhalation use

Germany

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Mikrogramm Druckgasinhalation, Lösung

80 μg

Pressurised inhalation, solution

Inhalation use

Germany

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Mikrogramm Druckgasinhalation, Lösung

160 μg

Pressurised inhalation, solution

Inhalation use

Greece

| Nycomed Hellas S.A. |
| --- |
| Kifissias Ave 196 |
| GR-15231 Chalandri |

Nycomed Hellas S.A.

Kifissias Ave 196

GR-15231 Chalandri

Alvesco 80 mcg/Dose

80 μg

Pressurised inhalation, solution

Inhalation use

Greece

| Nycomed Hellas S.A. |
| --- |
| Kifissias Ave 196 |
| GR-15231 Chalandri |

Nycomed Hellas S.A.

Kifissias Ave 196

GR-15231 Chalandri

Alvesco 160 mcg/Dose

160 μg

Pressurised inhalation, solution

Inhalation use

Greece

| Nycomed Hellas S.A. |
| --- |
| Kifissias Ave 196 |
| GR-15231 Chalandri |

Nycomed Hellas S.A.

Kifissias Ave 196

GR-15231 Chalandri

Freathe 80 mcg/Dose

80 μg

Pressurised inhalation, solution

Inhalation use

Greece

| Nycomed Hellas S.A. |
| --- |
| Kifissias Ave 196 |
| GR-15231 Chalandri |

Nycomed Hellas S.A.

Kifissias Ave 196

GR-15231 Chalandri

Freathe 160 mcg/Dose

160 μg

Pressurised inhalation, solution

Inhalation use

Greece

| Nycomed Hellas S.A. |
| --- |
| Kifissias Ave 196 |
| GR-15231 Chalandri |

Nycomed Hellas S.A.

Kifissias Ave 196

GR-15231 Chalandri

Amavio 80 mcg/Dose

80 μg

Pressurised inhalation, solution

Inhalation use

Greece

| Nycomed Hellas S.A. |
| --- |
| Kifissias Ave 196 |
| GR-15231 Chalandri |

Nycomed Hellas S.A.

Kifissias Ave 196

GR-15231 Chalandri

Amavio 160 mcg/Dose

160 μg

Pressurised inhalation, solution

Inhalation use

Hungary

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 mikrogramm túlnyomásos inhalációs oldat

40 μg

Pressurised inhalation, solution

Inhalation use

Hungary

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 mikrogramm túlnyomásos inhalációs oldat

80 μg

Pressurised inhalation, solution

Inhalation use

Hungary

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 mikrogramm túlnyomásos inhalációs oldat

160 μg

Pressurised inhalation, solution

Inhalation use

Iceland

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 innúdalyf

40 μg

Pressurised inhalation, solution

Inhalation use

Iceland

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 innúdalyf

80 μg

Pressurised inhalation, solution

Inhalation use

Iceland

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 innúdalyf

160 μg

Pressurised inhalation, solution

Inhalation use

Ireland

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 micrograms pressurised inhalation solution

40 μg

Pressurised inhalation, solution

Inhalation use

Ireland

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 micrograms pressurised inhalation solution

80 μg

Pressurised inhalation, solution

Inhalation use

Ireland

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 micrograms pressurised inhalation solution

160 μg

Pressurised inhalation, solution

Inhalation use

Italy

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

40 μg

Pressurised inhalation, solution

Inhalation use

Italy

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

80 μg

Pressurised inhalation, solution

Inhalation use

Italy

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

160 μg

Pressurised inhalation, solution

Inhalation use

Latvia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 inhalators

40 μg

Pressurised inhalation, solution

Inhalation use

Latvia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 inhalators

80 μg

Pressurised inhalation, solution

Inhalation use

Latvia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 inhalators

160 μg

Pressurised inhalation, solution

Inhalation use

Lithuania

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

40 μg

Pressurised inhalation, solution

Inhalation use

Lithuania

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

80 μg

Pressurised inhalation, solution

Inhalation use

Lithuania

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

160 μg

Pressurised inhalation, solution

Inhalation use

Luxembourg

| Nycomed Belgium s.c.a./c.v.a. |
| --- |
| Gentsesteenweg 615 |
| B-1080 Brussels |

Nycomed Belgium s.c.a./c.v.a.

Gentsesteenweg 615

B-1080 Brussels

Alvesco 40 Aérosol doseur

40 μg

Pressurised inhalation, solution

Inhalation use

Luxembourg

| Nycomed Belgium s.c.a./c.v.a. |
| --- |
| Gentsesteenweg 615 |
| B-1080 Brussels |

Nycomed Belgium s.c.a./c.v.a.

Gentsesteenweg 615

B-1080 Brussels

Alvesco 80 Aérosol doseur

80 μg

Pressurised inhalation, solution

Inhalation use

Luxembourg

| Nycomed Belgium s.c.a./c.v.a. |
| --- |
| Gentsesteenweg 615 |
| B-1080 Brussels |

Nycomed Belgium s.c.a./c.v.a.

Gentsesteenweg 615

B-1080 Brussels

Alvesco 160 Aérosol doseur

160 μg

Pressurised inhalation, solution

Inhalation use

Malta

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 Inhaler

40 μg

Pressurised inhalation, solution

Inhalation use

Malta

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Inhaler

80 μg

Pressurised inhalation, solution

Inhalation use

Malta

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Inhaler

160 μg

Pressurised inhalation, solution

Inhalation use

Netherlands

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 Inhalator

40 μg

Pressurised inhalation, solution

Inhalation use

Netherlands

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Inhalator

80 μg

Pressurised inhalation, solution

Inhalation use

Netherlands

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Inhalator

160 μg

Pressurised inhalation, solution

Inhalation use

Norway

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 micrograms/dose inhalasjonsaerosol, oppløsing

40 μg

Pressurised inhalation, solution

Inhalation use

Norway

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 micrograms/dose inhalasjonsaerosol, oppløsing

80 μg

Pressurised inhalation, solution

Inhalation use

Norway

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 micrograms/dose inhalasjonsaerosol, oppløsing

160 μg

Pressurised inhalation, Solution

Inhalation use

Poland

| Nycomed Pharma Sp. z o.o. |
| --- |
| Al. Jerozolimskie 146 A |
| PL-02-305 Warszawa |

Nycomed Pharma Sp. z o.o.

Al. Jerozolimskie 146 A

PL-02-305 Warszawa

Alvesco 40

40 μg

Pressurised inhalation, solution

Inhalation use

Poland

| Nycomed Pharma Sp. z o.o. |
| --- |
| Al. Jerozolimskie 146 A |
| PL-02-305 Warszawa |

Nycomed Pharma Sp. z o.o.

Al. Jerozolimskie 146 A

PL-02-305 Warszawa

Alvesco 80

80 μg

Pressurised inhalation, solution

Inhalation use

Poland

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160

160 μg

Pressurised inhalation, solution

Inhalation use

Portugal

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 Inalador

40 μg

Pressurised inhalation, solution

Inhalation use

Portugal

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Inalador

80 μg

Pressurised inhalation, solution

Inhalation use

Portugal

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Inalador

160 μg

Pressurised inhalation, solution

Inhalation use

Romania

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 Inhaler

40 μg

Pressurised inhalation, solution

Inhalation use

Romania

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Inhaler

80 μg

Pressurised inhalation, solution

Inhalation use

Romania

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Inhaler

160 μg

Pressurised inhalation, solution

Inhalation use

Slovakia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 Inhalátor

40 μg

Pressurised inhalation, solution

Inhalation use

Slovakia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Inhalátor

80 μg

Pressurised inhalation, solution

Inhalation use

Slovakia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Inhalátor

160 μg

Pressurised inhalation, solution

Inhalation use

Slovenia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 μg inhalacijska raztopina pod tlakom

40 μg

Pressurised inhalation, solution

Inhalation use

Slovenia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 μg inhalacijska raztopina pod tlakom

80 μg

Pressurised inhalation, solution

Inhalation use

Slovenia

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 μg inhalacijska raztopina pod tlakom

160 μg

Pressurised inhalation, solution

Inhalation use

Spain

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 mcg solución para inhalación en envase a presión

40 μg

Pressurised inhalation, solution

Inhalation use

Spain

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 mcg solución para inhalación en envase a presión

80 μg

Pressurised inhalation, solution

Inhalation use

Spain

| Altana Pharma AG |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Altana Pharma AG

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 mcg solución para inhalación en envase a presión

160 μg

Pressurised inhalation, solution

Inhalation use

Sweden

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

40 μg/dose

Pressurised inhalation, solution

Inhalation use

Sweden

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

80 μg/dose

Pressurised inhalation, solution

Inhalation use

Sweden

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco

160 μg/dose

Pressurised inhalation, solution

Inhalation use

United Kingdom

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 40 Inhaler

40 μg

Pressurised inhalation, solution

Inhalation use

United Kingdom

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 80 Inhaler

80 μg

Pressurised inhalation, solution

Inhalation use

United Kingdom

| Nycomed GmbH |
| --- |
| Byk-Gulden-Straße 2 |
| D-78467 Konstanz |

Nycomed GmbH

Byk-Gulden-Straße 2

D-78467 Konstanz

Alvesco 160 Inhaler

160 μg

Pressurised inhalation, solution

Inhalation use

---

ANNEX II

LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, APPLICANTS/MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | (Invented) name | Strength | Pharmaceutical Form | Route of administration | Content
  (concentration) |
| --- | --- | --- | --- | --- | --- | --- |
| Austria | Merck Sharp & Dohme GmbH |
| Donau-City-Straße 6 |
| A-1220 Vienne |

Member State

Marketing Authorisation Holder

(Invented) name

Strength

Pharmaceutical Form

Route of administration

Content

(concentration)

Austria

Merck Sharp & Dohme GmbH

Donau-City-Straße 6

A-1220 Vienne

Singulair 4 mg — Kautabletten für Kleinkinder

4 mg

Chewable tablets

Oral use

4 mg

Belgium

| Merck Sherp & Dohme |
| --- |
| Chaussée de Waterloo 1135 |
| B-1180 Bruxelles |

Merck Sherp & Dohme

Chaussée de Waterloo 1135

B-1180 Bruxelles

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Bulgaria

| Merck Sharp and Dohme Bulgaria EOOD |
| --- |
| 55, Nikola Vaptzarov blvd. |
| EXPO 2000, east wing, sectors B1 & B2, 1st fl. |
| BG-1407 Sofia |

Merck Sharp and Dohme Bulgaria EOOD

55, Nikola Vaptzarov blvd.

EXPO 2000, east wing, sectors B1 & B2, 1st fl.

BG-1407 Sofia

Singulair

4 mg

Granules

Oral use

Bulgaria

| Merck Sharp and Dohme Bulgaria EOOD |
| --- |
| 55, Nikola Vaptzarov blvd. |
| EXPO 2000, east wing, sectors B1 & B2, 1st fl. |
| BG-1407 Sofia |

Merck Sharp and Dohme Bulgaria EOOD

55, Nikola Vaptzarov blvd.

EXPO 2000, east wing, sectors B1 & B2, 1st fl.

BG-1407 Sofia

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Cyprus

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Granules

Oral use

Cyprus

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair Paediatric

4 mg

Chewable tablets

Oral use

4 mg

Czech Republic

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair 4 Mini

4 mg

Chewable tablets

Oral use

4 mg

Denmark

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Estonia

| Merck Sharp & Dohme OÜ |
| --- |
| Peterburi tee 46 |
| EE-11415 Tallinn |

Merck Sharp & Dohme OÜ

Peterburi tee 46

EE-11415 Tallinn

Singulair Mini 4 mg

4 mg

Granules

Oral use

Estonia

| Merck Sharp & Dohme OÜ |
| --- |
| Peterburi tee 46 |
| EE-11415 Tallinn |

Merck Sharp & Dohme OÜ

Peterburi tee 46

EE-11415 Tallinn

Singulair 4 mg

4 mg

Chewable tablets

Oral use

4 mg

Finland

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Granules

Oral use

Finland

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Germany

| Dieckmann Arzneimittel GmbH |
| --- |
| Lindenplatz 1 |
| D-85540 Haar |

Dieckmann Arzneimittel GmbH

Lindenplatz 1

D-85540 Haar

Singulair mini 4 mg Granulat

4 mg

Granules

Oral use

Germany

| Dieckmann Arzneimittel GmbH |
| --- |
| Lindenplatz 1 |
| D-85540 Haar |

Dieckmann Arzneimittel GmbH

Lindenplatz 1

D-85540 Haar

Singulair mini 4 mg Kautabletten

4 mg

Chewable tablets

Oral use

4 mg

Greece

| VIANEX A.E. |
| --- |
| Tatoiou Street |
| GR-146 71 Nea Erythrea/GR-146 71 Νέα Ερυθραία |

VIANEX A.E.

Tatoiou Street

GR-146 71 Nea Erythrea/GR-146 71 Νέα Ερυθραία

Singulair

4 mg

Granules

Oral use

Greece

| VIANEX A.E. |
| --- |
| Tatoiou Street |
| GR-146 71 Nea Erythrea/GR-146 71 Νέα Ερυθραία |

VIANEX A.E.

Tatoiou Street

GR-146 71 Nea Erythrea/GR-146 71 Νέα Ερυθραία

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Hungary

| MSD Magyarország Kft. |
| --- |
| Alkotás u. 50 |
| H-1123 Budapest |

MSD Magyarország Kft.

Alkotás u. 50

H-1123 Budapest

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Iceland

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Granules

Oral use

Iceland

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Ireland

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN119BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN119BU

United Kingdom

Singulair Paediatric

4 mg

Granules

Oral use

Ireland

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN119BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN119BU

United Kingdom

Singulair Paediatric

4 mg

Chewable Tablets

Oral use

4 mg

Italy

| Merck Sharp E Dohme (Italia) S.p.A. |
| --- |
| Via G. Fabbroni, 6 |
| I-00191 Roma |

Merck Sharp E Dohme (Italia) S.p.A.

Via G. Fabbroni, 6

I-00191 Roma

Singulair

4 mg

Granules

Oral use

Italy

| Istituto Gentili S.p.A |
| --- |
| Via B. Croce, 37 |
| I-56125 Pisa |

Istituto Gentili S.p.A

Via B. Croce, 37

I-56125 Pisa

Montegen

4 mg

Granules

Oral use

Italy

| Merck Sharp E Dohme (Italia) S.p.A. |
| --- |
| Via G. Fabbroni, 6 |
| I-00191 Roma |

Merck Sharp E Dohme (Italia) S.p.A.

Via G. Fabbroni, 6

I-00191 Roma

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Italy

| Istituto Gentili S.p.A |
| --- |
| Via B. Croce, 37 |
| I-56125 Pisa |

Istituto Gentili S.p.A

Via B. Croce, 37

I-56125 Pisa

Montegen

4 mg

Chewable tablets

Oral use

4 mg

Latvia

| SIA “Merck Sharp & Dohme Latvija” |
| --- |
| Skanstes 13, second floor |
| LV-1013 Riga |

SIA “Merck Sharp & Dohme Latvija”

Skanstes 13, second floor

LV-1013 Riga

Singulair mini 4 mg granulas

4 mg

Granules

Oral use

Latvia

| SIA “Merck Sharp & Dohme Latvija” |
| --- |
| Skanstes 13, second floor |
| LV-1013 Riga |

SIA “Merck Sharp & Dohme Latvija”

Skanstes 13, second floor

LV-1013 Riga

Singulair 4 mg košļājamās tabletes

4 mg

Chewable tablets

Oral use

4 mg

Lithuania

| Merck Sharp & Dohme |
| --- |
| UAB, Kestucio str. 59/27 |
| LT-08124 Vilnius |

Merck Sharp & Dohme

UAB, Kestucio str. 59/27

LT-08124 Vilnius

Singulair Mini

4 mg

Granules

Oral use

Lithuania

| Merck Sharp & Dohme |
| --- |
| UAB, Kestucio str. 59/27 |
| LT-08124 Vilnius |

Merck Sharp & Dohme

UAB, Kestucio str. 59/27

LT-08124 Vilnius

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Luxembourg

| Merck Sharp & Dohme |
| --- |
| Chaussée de Waterloo 1135 |
| B-1180 Bruxelles |

Merck Sharp & Dohme

Chaussée de Waterloo 1135

B-1180 Bruxelles

Singulair Mini

4 mg

Granules

Oral use

Luxembourg

| Merck Sharp & Dohme B.V. |
| --- |
| Chaussée de Waterloo 1135 |
| B-1180 Bruxelles |

Merck Sharp & Dohme B.V.

Chaussée de Waterloo 1135

B-1180 Bruxelles

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Malta

| Merck Sharp & Dohme |
| --- |
| Hertfordshire Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme

Hertfordshire Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

Singulair Paediatric 4 mg Granules

4 mg

Granules

Oral use

Malta

| Merck Sharp & Dohme |
| --- |
| Hertfordshire Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme

Hertfordshire Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

Singulair Paediatric 4 mg

4 mg

Chewable Tablets

Oral use

4 mg

Netherlands

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair Kleuter

4 mg

Chewable tablets

Oral use

4 mg

Norway

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Granules

Oral use

Norway

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Chewable tablets

Oral use

4 mg

Poland

| MSD Polska Sp. z o.o. |
| --- |
| Ul. Chłodna 51 |
| PL-00-867 Varsovie |

MSD Polska Sp. z o.o.

Ul. Chłodna 51

PL-00-867 Varsovie

Singulair 4

4 mg

Chewable tablets

Oral use

4 mg

Portugal

| Merck Sharp & Dohme, Lda. |
| --- |
| Quinta da Fonte — Edifício Vasco da Gama, n.o 19 — Porto Salvo |
| P.O. Box 214 |
| PT-2770-192 Paço d'Arcos |

Merck Sharp & Dohme, Lda.

Quinta da Fonte — Edifício Vasco da Gama, n.o 19 — Porto Salvo

P.O. Box 214

PT-2770-192 Paço d'Arcos

Singulair Infantil 4 mg Granulado

4 mg

Granules

Oral use

Portugal

| Merck Sharp & Dohme, Lda. |
| --- |
| Quinta da Fonte — Edifício Vasco da Gama, n.o 19 — Porto Salvo |
| P.O. Box 214 |
| PT-2770-192 Paço d'Arcos |

Merck Sharp & Dohme, Lda.

Quinta da Fonte — Edifício Vasco da Gama, n.o 19 — Porto Salvo

P.O. Box 214

PT-2770-192 Paço d'Arcos

Singulair Infantil

4 mg

Chewable tablets

Oral use

4 mg

Romania

| Merck Sharp & Dohme Romania S.R.L. |
| --- |
| Bucharest Business Park |
| Şos. Bucureşti-Ploieşti, nr. 1A |
| Corp clădire C1, Etaj 3 |
| Sector 1, Bucarest |
| România |

Merck Sharp & Dohme Romania S.R.L.

Bucharest Business Park

Şos. Bucureşti-Ploieşti, nr. 1A

Corp clădire C1, Etaj 3

Sector 1, Bucarest

România

Singulair, granule, 4 mg/plic

4 mg

Granules

Oral use

Romania

| Merck Sharp & Dohme Romania S.R.L. |
| --- |
| Bucharest Business Park |
| Şos. Bucureşti-Ploieşti, nr.1A |
| Corp clădire C1, Etaj 3 |
| Sector 1, Bucarest |
| România |

Merck Sharp & Dohme Romania S.R.L.

Bucharest Business Park

Şos. Bucureşti-Ploieşti, nr.1A

Corp clădire C1, Etaj 3

Sector 1, Bucarest

România

Singulair 4 mg, comprimate masticabile

4 mg

Chewable tablets

Oral use

4 mg

Slovenia

| Merck Sharp & Dohme |
| --- |
| Šmartinska cesta 140 |
| SLO-1000 Ljubljana |

Merck Sharp & Dohme

Šmartinska cesta 140

SLO-1000 Ljubljana

Singulair 4 mg zrnca

4 mg

Granules

Oral use

Slovenia

| Merck Sharp & Dohme |
| --- |
| Šmartinska cesta 140 |
| SLO-1000 Ljubljana |

Merck Sharp & Dohme

Šmartinska cesta 140

SLO-1000 Ljubljana

Singulair 4 mg žvečljive tablete

4 mg

Chewable tablets

Oral use

4 mg

Slovakia

| Merck Sharp & Dohme B.V. |
| --- |
| Waarderweg 39 |
| 2031 BN Haarlem |
| P.O. Box 581 |
| 2003 PC Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Waarderweg 39

2031 BN Haarlem

P.O. Box 581

2003 PC Haarlem

Nederland

Singulair 4 mg

4 mg

Chewable tablets

Oral use

4 mg

Spain

| Merck Sharp and Dohme de España, SA |
| --- |
| Josefa Valcarcel, no 38 |
| E-28027 Madrid |

Merck Sharp and Dohme de España, SA

Josefa Valcarcel, no 38

E-28027 Madrid

Singulair 4 mg granulado

4 mg

Granules

Oral use

Spain

| Merck Sharp and Dohme de España, SA |
| --- |
| Josefa Valcarcel, no 38 |
| E-28027 Madrid |

Merck Sharp and Dohme de España, SA

Josefa Valcarcel, no 38

E-28027 Madrid

Singulair 4 mg comprimidos masticables

4 mg

Chewable tablets

Oral use

4 mg

Sweden

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Granules

Oral use

Sweden

| Merck Sharp & Dohme B.V. |
| --- |
| Postbox 581 |
| Waarderweg 39 |
| 2031 BN Haarlem |
| Nederland |

Merck Sharp & Dohme B.V.

Postbox 581

Waarderweg 39

2031 BN Haarlem

Nederland

Singulair

4 mg

Chewable tablets

Oral use

4 mg

United Kingdom

| Merck Sharp & Dohme Limited |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Limited

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

Singulair Paediatric 4 mg Granules

4 mg

Granules

Oral use

United Kingdom

| Merck Sharp & Dohme Limited |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Limited

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

Singulair Paediatric 4 mg Chewable tablets

4 mg

Chewable Tablets

Oral use

4 mg

---

ANNEX III

LIST OF THE NAMES, PHARMACEUTICAL FORM(S), STRENGTH(S) OF THE MEDICINAL PRODUCT(S), ROUTE(S) OF ADMINISTRATION, APPLICANT(S) MARKETING AUTHORISATION HOLDER(S) IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Invented name | Strength | Pharmaceutical Form | Route of administration |
| --- | --- | --- | --- | --- | --- |
| Austria | Bayer HealthCare AG |
| D-51368 Leverkusen |

Member State

Marketing Authorisation Holder

Invented name

Strength

Pharmaceutical Form

Route of administration

Austria

Bayer HealthCare AG

D-51368 Leverkusen

Octegra 400 mg — Filmtabletten

400 mg

Film-coated tablet

Oral use

Belgium

| THERABEL PHARMA S.A. |
| --- |
| Rue Egide Van Ophem 108 |
| B-1180 Bruxelles |

THERABEL PHARMA S.A.

Rue Egide Van Ophem 108

B-1180 Bruxelles

Proflox 400 mg

400 mg

Film-coated tablet

Oral use

Germany

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Octegra 400 mg Filmtabletten

400 mg

Film-coated tablet

Oral use

Greece

| ELPEN A.E. Pharmaceutical Industry |
| --- |
| 95 Marathonos Av. |
| GR-190 09 Pikermi, Athens |

ELPEN A.E. Pharmaceutical Industry

95 Marathonos Av.

GR-190 09 Pikermi, Athens

Octegra

400 mg

Film-coated tablet

Oral use

Spain

| Procter and Gamble Pharmaceuticals Iberia, SL |
| --- |
| WTC Almeda park, edificio 1, 2a planta |
| Cornellá de Llobregat — Barcelona |
| España |

Procter and Gamble Pharmaceuticals Iberia, SL

WTC Almeda park, edificio 1, 2a planta

Cornellá de Llobregat — Barcelona

España

Octegra 400 mg comprimidos recubiertos con película

400 mg

Film-coated tablet

Oral use

France

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Octegra 400 mg, comprimé pelliculé

400 mg

Film-coated tablet

Oral use

Italy

| Innova Pharma S.p.A. |
| --- |
| Via M. Civitali, 1 |
| I-20148 Milano |

Innova Pharma S.p.A.

Via M. Civitali, 1

I-20148 Milano

Octegra

400 mg

Film-coated tablet

Oral use

Luxembourg

| Therabel Pharma |
| --- |
| 110 Rue Egide Van Ochem |
| B-1180 Bruxelles |

Therabel Pharma

110 Rue Egide Van Ochem

B-1180 Bruxelles

Proflox

400 mg

Film-coated tablet

Oral use

Netherlands

| Bayer Healthcare AG |
| --- |
| D-51368 Leverkusen |

Bayer Healthcare AG

D-51368 Leverkusen

Octegra 400 mg tabletten

400 mg

Film-coated tablet

Oral use

Portugal

| Bialfar — Produtos Farmacêuticos, SA |
| --- |
| À Av. da Siderurgia Nacional |
| P.O. Box 56 |
| P-4745-457 S. Mamede do Coronado |

Bialfar — Produtos Farmacêuticos, SA

À Av. da Siderurgia Nacional

P.O. Box 56

P-4745-457 S. Mamede do Coronado

Proflox

400 mg

Film-coated tablet

Oral use

---

ANNEX IV

LIST OF THE NAMES, PHARMACEUTICAL FORM(S), STRENGTH(S) OF THE MEDICINAL PRODUCT(S), ROUTE(S) OF ADMINISTRATION, APPLICANT(S) MARKETING AUTHORISATION HOLDER(S) IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Invented name | Strength | Pharmaceutical Form | Route of administration |
| --- | --- | --- | --- | --- | --- |
| Austria | Bayer HealthCare AG |
| D-51368 Leverkusen |

Member State

Marketing Authorisation Holder

Invented name

Strength

Pharmaceutical Form

Route of administration

Austria

Bayer HealthCare AG

D-51368 Leverkusen

Actira 400 mg — Filmtabletten

400 mg

Film-coated tablet

Oral use

Belgium

| Bayer AG |
| --- |
| D-51368 Leverkusen |

Bayer AG

D-51368 Leverkusen

Actira 400 mg

400 mg

Film-coated tablet

Oral use

Germany

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Actira 400 mg Filmtabletten

400 mg

Film-coated tablet

Oral use

Denmark

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Actira

400 mg

Film-coated tablet

Oral use

Greece

| Bayer plc |
| --- |
| Bayer Schering Pharma |
| Bayer House |
| Strawberry Hill |
| Newbury |
| Berkshire RG14 1JA |
| United Kingdom |

Bayer plc

Bayer Schering Pharma

Bayer House

Strawberry Hill

Newbury

Berkshire RG14 1JA

United Kingdom

Proflox

400 mg

Film-coated tablet

Oral use

Spain

| Química Farmaceútica Bayer, SL |
| --- |
| Av. Baix Llobregat, nos 3 y 5 |
| E-08970 Sant Joan Despi — Barcelona |

Química Farmaceútica Bayer, SL

Av. Baix Llobregat, nos 3 y 5

E-08970 Sant Joan Despi — Barcelona

Actira 400 mg comprimidos recubiertos con película

400 mg

Film-coated tablet

Oral use

Finland

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Actira

400 mg

Film-coated tablet

Oral use

Italy

| Sigma-Tau Industrie |
| --- |
| Farmaceutiche riunite S.p.A. |
| Viale Shakespeare, 47 |
| I-00144 Roma |

Sigma-Tau Industrie

Farmaceutiche riunite S.p.A.

Viale Shakespeare, 47

I-00144 Roma

Actira

400 mg

Film-coated tablet

Oral use

Luxembourg

| Bayer Healthcare AG |
| --- |
| D-51368 Leverkusen |

Bayer Healthcare AG

D-51368 Leverkusen

Actira

400 mg

Film-coated tablet

Oral use

Portugal

| Bayer AG |
| --- |
| D-51368 Leverkusen |

Bayer AG

D-51368 Leverkusen

Actira

400 mg

Film-coated tablet

Oral use

Sweden

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Actira

400 mg

Film-coated tablet

Oral use

---

ANNEX V

LIST OF THE NAMES, PHARMACEUTICAL FORM(S), STRENGTH(S) OF THE MEDICINAL PRODUCT(S), ROUTE(S) OF ADMINISTRATION, APPLICANT(S) MARKETING AUTHORISATION HOLDER(S) IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Invented name | Strength | Pharmaceutical Form | Route of administration |
| --- | --- | --- | --- | --- | --- |
| Austria | Bayer Austria Gesellschaft m.b.H. |
| Herbststraße 6-10 |
| A-1160 Wien |

Member State

Marketing Authorisation Holder

Invented name

Strength

Pharmaceutical Form

Route of administration

Austria

Bayer Austria Gesellschaft m.b.H.

Herbststraße 6-10

A-1160 Wien

Avelox 400 mg — Filmtabletten

400 mg

Film-coated tablet

Oral use

Belgium

| Bayer s.a.-n.v. |
| --- |
| Avenue Louise 143 |
| B-1050 Bruxelles |

Bayer s.a.-n.v.

Avenue Louise 143

B-1050 Bruxelles

Avelox 400 mg

400 mg

Film-coated tablet

Oral use

Cyprus

| Bayer Hellas S.A. |
| --- |
| Sorou 18-20 |
| GR-151 25 Marousi, Athens |

Bayer Hellas S.A.

Sorou 18-20

GR-151 25 Marousi, Athens

Avelox

400 mg

Film-coated tablet

Oral use

Czech Republic

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox

400 mg

Film-coated tablet

Oral use

Germany

| Bayer Vital GmbH |
| --- |
| D-51368 Leverkusen |

Bayer Vital GmbH

D-51368 Leverkusen

Avalox 400 mg Filmtabletten

400 mg

Film-coated tablet

Oral use

Denmark

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox

400 mg

Film-coated tablet

Oral use

Estonia

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox

400 mg

Film-coated tablet

Oral use

Greece

| Bayer Hellas S.A. |
| --- |
| Sorou 18-20 |
| GR-151 25 Marousi, Athens |

Bayer Hellas S.A.

Sorou 18-20

GR-151 25 Marousi, Athens

Avelox

400 mg

Film-coated tablet

Oral use

Spain

| Recordati España, SL |
| --- |
| Crta. De Zeneta, 149 |
| E-30588 Murcia |

Recordati España, SL

Crta. De Zeneta, 149

E-30588 Murcia

Havelox 400 mg comprimidos recubiertos con película

400 mg

Film-coated tablet

Oral use

Finland

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox

400 mg

Film-coated tablet

Oral use

France

| Bayer Santé |
| --- |
| 13, rue Jean Jaurès |
| F-92807 Puteaux Cedex |

Bayer Santé

13, rue Jean Jaurès

F-92807 Puteaux Cedex

Izilox 400 mg, comprimé pelliculé

400 mg

Film-coated tablet

Oral use

Hungary

| Bayer Hungária Kft |
| --- |
| Alkotás ut. 50 |
| H-1123 Budapest |

Bayer Hungária Kft

Alkotás ut. 50

H-1123 Budapest

Avelox

400 mg

Film-coated tablet

Oral use

Ireland

| Bayer Limited |
| --- |
| The Atrium |
| Blackthorn Road |
| Dublin 18 |
| Ireland |

Bayer Limited

The Atrium

Blackthorn Road

Dublin 18

Ireland

Avelox

400 mg

Film-coated tablet

Oral use

Italy

| Bayer S.p.A. |
| --- |
| Viale Certosa, 130 |
| I-20156 Milano |

Bayer S.p.A.

Viale Certosa, 130

I-20156 Milano

Avalox

400 mg

Film-coated tablet

Oral use

Lithuania

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox

400 mg

Film-coated tablet

Oral use

Luxembourg

| Bayer s.a.-n.v. |
| --- |
| Avenue Louise 143 |
| B-1050 Bruxelles |

Bayer s.a.-n.v.

Avenue Louise 143

B-1050 Bruxelles

Avelox

400 mg

Film-coated tablet

Oral use

Latvia

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox

400 mg

Film-coated tablet

Oral use

Malta

| Bayer Vital GmbH |
| --- |
| D-51368 Leverkusen |

Bayer Vital GmbH

D-51368 Leverkusen

Avalox

400 mg

Film-coated tablet

Oral use

Netherlands

| Bayer BV |
| --- |
| Energieweg 1 |
| 3641 RT Mijdrecht |
| Nederland |

Bayer BV

Energieweg 1

3641 RT Mijdrecht

Nederland

Avelox 400 mg tabletten

400 mg

Film-coated tablet

Oral use

Poland

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox

400 mg

Film-coated tablet

Oral use

Portugal

| BayHealth — Comercialização de Produtos Farmacêuticos Unipessoal, Lda. |
| --- |
| Rua Quinta do Pinheiro, n.o 5 |
| P-2794-003 Carnaxide |

BayHealth — Comercialização de Produtos Farmacêuticos Unipessoal, Lda.

Rua Quinta do Pinheiro, n.o 5

P-2794-003 Carnaxide

Avelox

400 mg

Film-coated tablet

Oral use

Sweden

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox

400 mg

Film-coated tablet

Oral use

Slovenia

| BAYER d.o.o. |
| --- |
| Bravničarjeva 13 |
| SLO-1000 Ljubljana |

BAYER d.o.o.

Bravničarjeva 13

SLO-1000 Ljubljana

Avelox 400 mg filmsko obložene tablete

400 mg

Film-coated tablet

Oral use

Slovakia

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

Avelox 400

400 mg

Film-coated tablet

Oral use

United Kingdom

| Bayer plc |
| --- |
| Bayer Schering Pharma |
| Bayer House |
| Strawberry Hill |
| Newbury |
| Berkshire RG14 1JA |
| United Kingdom |

Bayer plc

Bayer Schering Pharma

Bayer House

Strawberry Hill

Newbury

Berkshire RG14 1JA

United Kingdom

Avelox 400 mg Tablets

400 mg

Film-coated tablet

Oral use

---

ANNEX VI

LIST OF THE NAME, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTE OF ADMINISTRATION, APPLICANT(S) IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical Form | Route of administration |
| --- | --- | --- | --- | --- | --- | --- |
| Austria | | FGK Representative Service GmbH |
| Heimeranstraße 35 |
| D-80339 München |

Member State

Marketing Authorisation Holder

Applicant

Invented name

Strength

Pharmaceutical Form

Route of administration

Austria

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea

40 mg

Modified-release capsule, hard

Oral use

Finland

| FGK Representative Service GmbH |
| --- |
| Heimeranstraße 35 |
| D-80339 München |

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea

40 mg

Prolonged-release capsule, hard

Oral use

Germany

| FGK Representative Service GmbH |
| --- |
| Heimeranstraße 35 |
| D-80339 München |

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea

40 mg

Prolonged-release capsule, hard

Oral use

Ireland

| FGK Representative Service GmbH |
| --- |
| Heimeranstraße 35 |
| D-80339 München |

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea (1)

40 mg

Modified-release capsule, hard

Oral use

Italy

| FGK Representative Service GmbH |
| --- |
| Heimeranstraße 35 |
| D-80339 München |

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea

40 mg

Prolonged-release capsule, hard

Oral use

Luxembourg

| FGK Representative Service GmbH |
| --- |
| Heimeranstraße 35 |
| D-80339 München |

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea

40 mg

Prolonged-release capsule, hard

Oral use

Netherlands

| FGK Representative Service GmbH |
| --- |
| Heimeranstraße 35 |
| D-80339 München |

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea (1)

40 mg

Prolonged-release capsule, hard

Oral use

Sweden

| FGK Representative Service GmbH |
| --- |
| Heimeranstraße 35 |
| D-80339 München |

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea

40 mg

Modified-release capsule, hard

Oral use

United Kingdom

| FGK Representative Service GmbH |
| --- |
| Heimeranstraße 35 |
| D-80339 München |

FGK Representative Service GmbH

Heimeranstraße 35

D-80339 München

Oracea

40 mg

Prolonged-release capsule, hard

Oral use

---

(1)  Name approval pending.

---

ANNEX VII

LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | (Invented) Name | Strength | Pharmaceutical form | Route of administration |
| --- | --- | --- | --- | --- | --- |
| Austria | GlaxoSmithKline Pharma GmbH |
| Albert-Schweitzer-Gasse 6 |
| A-1140 Wien |

Member State

Marketing Authorisation Holder

(Invented) Name

Strength

Pharmaceutical form

Route of administration

Austria

GlaxoSmithKline Pharma GmbH

Albert-Schweitzer-Gasse 6

A-1140 Wien

Lamictal 5 mg — lösliche Tabletten

5 mg

Dispersible tablet

Oral use

Austria

| GlaxoSmithKline Pharma GmbH |
| --- |
| Albert-Schweitzer-Gasse 6 |
| A-1140 Wien |

GlaxoSmithKline Pharma GmbH

Albert-Schweitzer-Gasse 6

A-1140 Wien

Lamictal 25 mg — lösliche Tabletten

25 mg

Dispersible tablet

Oral use

Austria

| GlaxoSmithKline Pharma GmbH |
| --- |
| Albert-Schweitzer-Gasse 6 |
| A-1140 Wien |

GlaxoSmithKline Pharma GmbH

Albert-Schweitzer-Gasse 6

A-1140 Wien

Lamictal 50 mg — lösliche Tabletten

50 mg

Dispersible tablet

Oral use

Austria

| GlaxoSmithKline Pharma GmbH |
| --- |
| Albert-Schweitzer-Gasse 6 |
| A-1140 Wien |

GlaxoSmithKline Pharma GmbH

Albert-Schweitzer-Gasse 6

A-1140 Wien

Lamictal 100 mg — lösliche Tabletten

100 mg

Dispersible tablet

Oral use

Austria

| GlaxoSmithKline Pharma GmbH |
| --- |
| Albert-Schweitzer-Gasse 6 |
| A-1140 Wien |

GlaxoSmithKline Pharma GmbH

Albert-Schweitzer-Gasse 6

A-1140 Wien

Lamictal 200 mg — lösliche Tabletten

200 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal

25 mg

Tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal

50 mg

Tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal

100 mg

Tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal Dispersible 25 mg Starter-Pack Mono

25 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal Dispersible 25 mg Starter-Pack Add-on

25 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal Dispersible 50 mg Starter-Pack add-on

50 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

2 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

5 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

25 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

50 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

100 mg

Dispersible tablet

Oral use

Belgium

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

200 mg

Dispersible tablet

Oral use

Bulgaria

| GlaxoSmithKline EOOD |
| --- |
| Ivan Vazov complex |
| Dimitar Manov street, bl. 10 |
| BG-1408 Sofia |

GlaxoSmithKline EOOD

Ivan Vazov complex

Dimitar Manov street, bl. 10

BG-1408 Sofia

Lamictal

25 mg

Tablet

Oral use

Bulgaria

| GlaxoSmithKline EOOD |
| --- |
| Ivan Vazov complex |
| Dimitar Manov street, bl. 10 |
| BG-1408 Sofia |

GlaxoSmithKline EOOD

Ivan Vazov complex

Dimitar Manov street, bl. 10

BG-1408 Sofia

Lamictal

50 mg

Tablet

Oral use

Bulgaria

| GlaxoSmithKline EOOD |
| --- |
| Ivan Vazov complex |
| Dimitar Manov street, bl. 10 |
| BG-1408 Sofia |

GlaxoSmithKline EOOD

Ivan Vazov complex

Dimitar Manov street, bl. 10

BG-1408 Sofia

Lamictal

100 mg

Tablet

Oral use

Bulgaria

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

5 mg

Dispersible tablet

Oral use

Cyprus

| Glaxo Group Ltd |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

5 mg

Dispersible tablet

Oral use

Cyprus

| Glaxo Group Ltd |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

25 mg

Dispersible tablet

Oral use

Cyprus

| Glaxo Group Ltd |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

50 mg

Dispersible tablet

Oral use

Cyprus

| Glaxo Group Ltd |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

100 mg

Dispersible tablet

Oral use

Cyprus

| Glaxo Group Ltd |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

200 mg

Dispersible tablet

Oral use

Czech Republic

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 25 mg

25 mg

Tablet

Oral use

Czech Republic

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 50 mg

50 mg

Tablet

Oral use

Czech Republic

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 100 mg

100 mg

Tablet

Oral use

Czech Republic

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 2 mg

2 mg

Dispersible tablet

Oral use

Czech Republic

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 5 mg

5 mg

Dispersible tablet

Oral use

Czech Republic

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 25 mg

25 mg

Dispersible tablet

Oral use

Czech Republic

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 50 mg

50 mg

Dispersible tablet

Oral use

Czech Republic

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 100 mg

100 mg

Dispersible tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

25 mg

Tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

50 mg

Tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

100 mg

Tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

200 mg

Tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

2 mg

Dispersible tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

5 mg

Dispersible tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

25 mg

Dispersible tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

50 mg

Dispersible tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

100 mg

Dispersible tablet

Oral use

Denmark

| GlaxoSmithKline Pharma A/S |
| --- |
| Nykær 68 |
| DK-2605 Brøndby |

GlaxoSmithKline Pharma A/S

Nykær 68

DK-2605 Brøndby

Lamictal

200 mg

Dispersible tablet

Oral use

Estonia

| Glaxo Wellcome Operations |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Wellcome Operations

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

2 mg

Dispersible tablet

Oral use

Estonia

| Glaxo Wellcome Operations |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Wellcome Operations

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

5 mg

Dispersible tablet

Oral use

Estonia

| Glaxo Wellcome Operations |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Wellcome Operations

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

25 mg

Dispersible tablet

Oral use

Estonia

| Glaxo Wellcome Operations |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Wellcome Operations

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

50 mg

Dispersible tablet

Oral use

Estonia

| Glaxo Wellcome Operations |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Wellcome Operations

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

100 mg

Dispersible tablet

Oral use

Estonia

| Glaxo Wellcome Operations |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Wellcome Operations

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

200 mg

Dispersible tablet

Oral use

Finland

| GlaxoSmithKline Oy |
| --- |
| Piispansilta 9 A |
| FI-02230 Espoo |

GlaxoSmithKline Oy

Piispansilta 9 A

FI-02230 Espoo

Lamictal

2 mg

Dispersible tablet

Oral use

Finland

| GlaxoSmithKline Oy |
| --- |
| Piispansilta 9 A |
| FI-02230 Espoo |

GlaxoSmithKline Oy

Piispansilta 9 A

FI-02230 Espoo

Lamictal

5 mg

Dispersible tablet

Oral use

Finland

| GlaxoSmithKline Oy |
| --- |
| Piispansilta 9 A |
| FI-02230 Espoo |

GlaxoSmithKline Oy

Piispansilta 9 A

FI-02230 Espoo

Lamictal

25 mg

Dispersible tablet

Oral use

Finland

| GlaxoSmithKline Oy |
| --- |
| Piispansilta 9 A |
| FI-02230 Espoo |

GlaxoSmithKline Oy

Piispansilta 9 A

FI-02230 Espoo

Lamictal

50 mg

Dispersible tablet

Oral use

Finland

| GlaxoSmithKline Oy |
| --- |
| Piispansilta 9 A |
| FI-02230 Espoo |

GlaxoSmithKline Oy

Piispansilta 9 A

FI-02230 Espoo

Lamictal

100 mg

Dispersible tablet

Oral use

Finland

| GlaxoSmithKline Oy |
| --- |
| Piispansilta 9 A |
| FI-02230 Espoo |

GlaxoSmithKline Oy

Piispansilta 9 A

FI-02230 Espoo

Lamictal

200 mg

Dispersible tablet

Oral use

France

| Laboratoire GlaxoSmithKline |
| --- |
| 100, route de Versailles |
| F-78163 Marly-le-Roi Cedex |

Laboratoire GlaxoSmithKline

100, route de Versailles

F-78163 Marly-le-Roi Cedex

Lamicstart 25 mg, comprimé

25 mg

Tablet

Oral use

France

| Laboratoire GlaxoSmithKline |
| --- |
| 100, route de Versailles |
| F-78163 Marly-le-Roi Cedex |

Laboratoire GlaxoSmithKline

100, route de Versailles

F-78163 Marly-le-Roi Cedex

Lamicstart 50 mg, comprimé

50 mg

Tablet

Oral use

France

| Laboratoire GlaxoSmithKline |
| --- |
| 100, route de Versailles |
| F-78163 Marly-le-Roi Cedex |

Laboratoire GlaxoSmithKline

100, route de Versailles

F-78163 Marly-le-Roi Cedex

Lamictal 2 mg, comprimé dispersible

2 mg

Dispersible tablet

Oral use

France

| Laboratoire GlaxoSmithKline |
| --- |
| 100, route de Versailles |
| F-78163 Marly-le-Roi Cedex |

Laboratoire GlaxoSmithKline

100, route de Versailles

F-78163 Marly-le-Roi Cedex

Lamictal 5 mg, comprimé dispersible ou à croquer

5 mg

Dispersible or chewable tablet

Oral use

France

| Laboratoire GlaxoSmithKline |
| --- |
| 100, route de Versailles |
| F-78163 Marly-le-Roi Cedex |

Laboratoire GlaxoSmithKline

100, route de Versailles

F-78163 Marly-le-Roi Cedex

Lamictal 25 mg, comprimé dispersible ou à croquer

25 mg

Dispersible or chewable tablet

Oral use

France

| Laboratoire GlaxoSmithKline |
| --- |
| 100, route de Versailles |
| F-78163 Marly-le-Roi Cedex |

Laboratoire GlaxoSmithKline

100, route de Versailles

F-78163 Marly-le-Roi Cedex

Lamictal 50 mg, comprimé dispersible ou à croquer

50 mg

Dispersible or chewable tablet

Oral use

France

| Laboratoire GlaxoSmithKline |
| --- |
| 100, route de Versailles |
| F-78163 Marly-le-Roi Cedex |

Laboratoire GlaxoSmithKline

100, route de Versailles

F-78163 Marly-le-Roi Cedex

Lamictal 100 mg, comprimé dispersible ou à croquer

100 mg

Dispersible or chewable tablet

Oral use

France

| Laboratoire GlaxoSmithKline |
| --- |
| 100, route de Versailles |
| F-78163 Marly-le-Roi Cedex |

Laboratoire GlaxoSmithKline

100, route de Versailles

F-78163 Marly-le-Roi Cedex

Lamictal 200 mg, comprimé dispersible ou à croquer

200 mg

Dispersible or chewable tablet

Oral use

Germany

| GlaxoSmithKline GmbH & Co. KG |
| --- |
| Theresienhöhe 11 |
| D-80339 München |

GlaxoSmithKline GmbH & Co. KG

Theresienhöhe 11

D-80339 München

Lamictal 2 mg Tabletten zur Herstellung einer Suspension zum Einnehmen

2 mg

Dispersible tablet

Oral use

Germany

| GlaxoSmithKline GmbH & Co. KG |
| --- |
| Theresienhöhe 11 |
| D-80339 München |

GlaxoSmithKline GmbH & Co. KG

Theresienhöhe 11

D-80339 München

Lamictal 5 mg Tabletten zur Herstellung einer Suspension zum Einnehmen

5 mg

Dispersible tablet

Oral use

Germany

| GlaxoSmithKline GmbH & Co. KG |
| --- |
| Theresienhöhe 11 |
| D-80339 München |

GlaxoSmithKline GmbH & Co. KG

Theresienhöhe 11

D-80339 München

Lamictal 25 mg Tabletten zur Herstellung einer Suspension zum Einnehmen

25 mg

Dispersible tablet

Oral use

Germany

| GlaxoSmithKline GmbH & Co. KG |
| --- |
| Theresienhöhe 11 |
| D-80339 München |

GlaxoSmithKline GmbH & Co. KG

Theresienhöhe 11

D-80339 München

Lamictal 50 mg Tabletten zur Herstellung einer Suspension zum Einnehmen

50 mg

Dispersible tablet

Oral use

Germany

| GlaxoSmithKline GmbH & Co. KG |
| --- |
| Theresienhöhe 11 |
| D-80339 München |

GlaxoSmithKline GmbH & Co. KG

Theresienhöhe 11

D-80339 München

Lamictal 100 mg Tabletten zur Herstellung einer Suspension zum Einnehmen

100 mg

Dispersible tablet

Oral use

Germany

| GlaxoSmithKline GmbH & Co. KG |
| --- |
| Theresienhöhe 11 |
| D-80339 München |

GlaxoSmithKline GmbH & Co. KG

Theresienhöhe 11

D-80339 München

Lamictal 200 mg Tabletten zur Herstellung einer Suspension zum Einnehmen

200 mg

Dispersible tablet

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

25 mg

Tablet

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

50 mg

Tablet

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

100 mg

Tablet

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

200 mg

Tablet

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

2 mg

Dispersible/Chewable tablets

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

5 mg

Dispersible/Chewable tablets

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

25 mg

Dispersible/Chewable tablets

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

50 mg

Dispersible/Chewable tablets

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

100 mg

Dispersible/Chewable tablets

Oral use

Greece

| GlaxoSmithKline α.ε.β.ε |
| --- |
| 266 Kifissias Ave |
| GR-152 32 Halandri, Athens |

GlaxoSmithKline α.ε.β.ε

266 Kifissias Ave

GR-152 32 Halandri, Athens

Lamictal

200 mg

Dispersible/Chewable tablets

Oral use

Hungary

| GlaxoSmithKline Kft. |
| --- |
| Csorsz u. 43. MOM Park Gesztenyes torony |
| HU-1124 Budapest |

GlaxoSmithKline Kft.

Csorsz u. 43. MOM Park Gesztenyes torony

HU-1124 Budapest

Lamictal

25 mg

Tablet

Oral use

Hungary

| GlaxoSmithKline Kft. |
| --- |
| Csorsz u. 43. MOM Park Gesztenyes torony |
| HU-1124 Budapest |

GlaxoSmithKline Kft.

Csorsz u. 43. MOM Park Gesztenyes torony

HU-1124 Budapest

Lamictal

50 mg

Tablet

Oral use

Hungary

| GlaxoSmithKline Kft. |
| --- |
| Csorsz u. 43. MOM Park Gesztenyes torony |
| HU-1124 Budapest |

GlaxoSmithKline Kft.

Csorsz u. 43. MOM Park Gesztenyes torony

HU-1124 Budapest

Lamictal

100 mg

Tablet

Oral use

Hungary

| GlaxoSmithKline Kft. |
| --- |
| Csorsz u. 43. MOM Park Gesztenyes torony |
| HU-1124 Budapest |

GlaxoSmithKline Kft.

Csorsz u. 43. MOM Park Gesztenyes torony

HU-1124 Budapest

Lamictal

5 mg

Dispersible tablet

Oral use

Hungary

| GlaxoSmithKline Kft. |
| --- |
| Csorsz u. 43. MOM Park Gesztenyes torony |
| HU-1124 Budapest |

GlaxoSmithKline Kft.

Csorsz u. 43. MOM Park Gesztenyes torony

HU-1124 Budapest

Lamictal

200 mg

Dispersible tablet

Oral use

Iceland

| GlaxoSmithKline ehf. |
| --- |
| Thverholt 14 |
| IS-105 Reykjavik |

GlaxoSmithKline ehf.

Thverholt 14

IS-105 Reykjavik

Lamictal

2 mg

Dispersible tablet

Oral use

Iceland

| GlaxoSmithKline ehf. |
| --- |
| Thverholt 14 |
| IS-105 Reykjavik |

GlaxoSmithKline ehf.

Thverholt 14

IS-105 Reykjavik

Lamictal

5 mg

Dispersible tablet

Oral use

Iceland

| GlaxoSmithKline ehf. |
| --- |
| Thverholt 14 |
| IS-105 Reykjavik |

GlaxoSmithKline ehf.

Thverholt 14

IS-105 Reykjavik

Lamictal

25 mg

Dispersible tablet

Oral use

Iceland

| GlaxoSmithKline ehf. |
| --- |
| Thverholt 14 |
| IS-105 Reykjavik |

GlaxoSmithKline ehf.

Thverholt 14

IS-105 Reykjavik

Lamictal

50 mg

Dispersible tablet

Oral use

Iceland

| GlaxoSmithKline ehf. |
| --- |
| Thverholt 14 |
| IS-105 Reykjavik |

GlaxoSmithKline ehf.

Thverholt 14

IS-105 Reykjavik

Lamictal

100 mg

Dispersible tablet

Oral use

Iceland

| GlaxoSmithKline ehf. |
| --- |
| Thverholt 14 |
| IS-105 Reykjavik |

GlaxoSmithKline ehf.

Thverholt 14

IS-105 Reykjavik

Lamictal

200 mg

Dispersible tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal tablets 25 mg

25 mg

Tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal tablets 50 mg

50 mg

Tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal tablets 100 mg

100 mg

Tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal tablets 200 mg

200 mg

Tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal 2 mg dispersible tablets

2 mg

Dispersible tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal dispersible tablets 5 mg

5 mg

Dispersible tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal dispersible tablets 25 mg

25 mg

Dispersible tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal dispersible tablets 50 mg

50 mg

Dispersible tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal dispersible tablets 100 mg

100 mg

Dispersible tablet

Oral use

Ireland

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal dispersible tablets 200 mg

200 mg

Dispersible tablet

Oral use

Italy

| GlaxoSmithKline SpA |
| --- |
| Via Fleming, 2 |
| I-37135 Verona |

GlaxoSmithKline SpA

Via Fleming, 2

I-37135 Verona

Lamictal

5 mg

Dispersible Tablet

Oral use

Italy

| GlaxoSmithKline SpA |
| --- |
| Via Fleming, 2 |
| I-37135 Verona |

GlaxoSmithKline SpA

Via Fleming, 2

I-37135 Verona

Lamictal

25 mg

Dispersible tablet

Oral use

Italy

| GlaxoSmithKline SpA |
| --- |
| Via Fleming, 2 |
| I-37135 Verona |

GlaxoSmithKline SpA

Via Fleming, 2

I-37135 Verona

Lamictal

50 mg

Dispersible tablet

Oral use

Italy

| GlaxoSmithKline SpA |
| --- |
| Via Fleming, 2 |
| I-37135 Verona |

GlaxoSmithKline SpA

Via Fleming, 2

I-37135 Verona

Lamictal

100 mg

Dispersible tablet

Oral use

Italy

| GlaxoSmithKline SpA |
| --- |
| Via Fleming, 2 |
| I-37135 Verona |

GlaxoSmithKline SpA

Via Fleming, 2

I-37135 Verona

Lamictal

200 mg

Dispersible tablet

Oral use

Latvia

| GlaxoSmithKline Latvia SIA |
| --- |
| Bruņinieku iela 5 |
| LV-1001 Riga |

GlaxoSmithKline Latvia SIA

Bruņinieku iela 5

LV-1001 Riga

Lamictal 2 mg dispersible tablets

2 mg

Dispersible tablet

Oral use

Latvia

| GlaxoSmithKline Latvia SIA |
| --- |
| Bruņinieku iela 5 |
| LV-1001 Riga |

GlaxoSmithKline Latvia SIA

Bruņinieku iela 5

LV-1001 Riga

Lamictal 5 mg dispersible tablets

5 mg

Dispersible tablet

Oral use

Latvia

| GlaxoSmithKline Latvia SIA |
| --- |
| Bruņinieku iela 5 |
| LV-1001 Riga |

GlaxoSmithKline Latvia SIA

Bruņinieku iela 5

LV-1001 Riga

Lamictal 25 mg dispersible tablets

25 mg

Dispersible tablet

Oral use

Latvia

| GlaxoSmithKline Latvia SIA |
| --- |
| Bruņinieku iela 5 |
| LV-1001 Riga |

GlaxoSmithKline Latvia SIA

Bruņinieku iela 5

LV-1001 Riga

Lamictal 50 mg dispersible tablets

50 mg

Dispersible tablet

Oral use

Latvia

| GlaxoSmithKline Latvia SIA |
| --- |
| Bruņinieku iela 5 |
| LV-1001 Riga |

GlaxoSmithKline Latvia SIA

Bruņinieku iela 5

LV-1001 Riga

Lamictal 100 mg dispersible tablets

100 mg

Dispersible tablet

Oral use

Latvia

| GlaxoSmithKline Latvia SIA |
| --- |
| Bruņinieku iela 5 |
| LV-1001 Riga |

GlaxoSmithKline Latvia SIA

Bruņinieku iela 5

LV-1001 Riga

Lamictal 200 mg dispersible tablets

200 mg

Dispersible tablet

Oral use

Lithuania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

5 mg

Dispersible tablet

Oral use

Lithuania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

25 mg

Dispersible tablet

Oral use

Lithuania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

50 mg

Dispersible tablet

Oral use

Lithuania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

100 mg

Dispersible tablet

Oral use

Lithuania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal

200 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal

25 mg

Tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal

50 mg

Tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal

100 mg

Tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal Dispersible 25mg Starter-Pack Mono

25 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal Dispersible 25mg Starter-Pack Add-on

25 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal Dispersible 50mg Starter-Pack add-on

50 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

2 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

5 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

25 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

50 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

100 mg

Dispersible tablet

Oral use

Luxembourg

| GlaxoSmithKline s.a. |
| --- |
| Rue du Tilleul 13 |
| B-1332 Genval |

GlaxoSmithKline s.a.

Rue du Tilleul 13

B-1332 Genval

Lamictal dispersible

200 mg

Dispersible tablet

Oral use

Malta

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal

25 mg

Tablet

Oral use

Malta

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal

50 mg

Tablet

Oral use

Malta

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal

100 mg

Tablet

Oral use

Malta

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal

2 mg

Dispersible/Chewable tablet

Oral use

Malta

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal

5 mg

Dispersible/Chewable tablet

Oral use

Malta

| GlaxoSmithKline (Ireland) Ltd |
| --- |
| Stonemasons Way |
| Rathfarnham |
| Dublin 16 |
| Ireland |

GlaxoSmithKline (Ireland) Ltd

Stonemasons Way

Rathfarnham

Dublin 16

Ireland

Lamictal

25 mg

Dispersible/Chewable tablet

Oral use

Netherlands

| GlaxoSmithKline BV |
| --- |
| Huis ter Heideweg 62 |
| 3705 LZ Zeist |
| Nederland |

GlaxoSmithKline BV

Huis ter Heideweg 62

3705 LZ Zeist

Nederland

Lamictal 2 Dispers

2 mg

Dispersible tablet

Oral use

Netherlands

| GlaxoSmithKline BV |
| --- |
| Huis ter Heideweg 62 |
| 3705 LZ Zeist |
| Nederland |

GlaxoSmithKline BV

Huis ter Heideweg 62

3705 LZ Zeist

Nederland

Lamictal 5 Dispers

5 mg

Dispersible tablet

Oral use

Netherlands

| GlaxoSmithKline BV |
| --- |
| Huis ter Heideweg 62 |
| 3705 LZ Zeist |
| Nederland |

GlaxoSmithKline BV

Huis ter Heideweg 62

3705 LZ Zeist

Nederland

Lamictal 25 Dispers

25 mg

Dispersible tablet

Oral use

Netherlands

| GlaxoSmithKline BV |
| --- |
| Huis ter Heideweg 62 |
| 3705 LZ Zeist |
| Nederland |

GlaxoSmithKline BV

Huis ter Heideweg 62

3705 LZ Zeist

Nederland

Lamictal 50 Dispers

50 mg

Dispersible tablet

Oral use

Netherlands

| GlaxoSmithKline BV |
| --- |
| Huis ter Heideweg 62 |
| 3705 LZ Zeist |
| Nederland |

GlaxoSmithKline BV

Huis ter Heideweg 62

3705 LZ Zeist

Nederland

Lamictal 100 Dispers

100 mg

Dispersible tablet

Oral use

Netherlands

| GlaxoSmithKline BV |
| --- |
| Huis ter Heideweg 62 |
| 3705 LZ Zeist |
| Nederland |

GlaxoSmithKline BV

Huis ter Heideweg 62

3705 LZ Zeist

Nederland

Lamictal 200 Dispers

200 mg

Dispersible tablet

Oral use

Norway

| GlaxoSmithKline AS |
| --- |
| Forskningsveien 2a |
| Postbox 180 Vinderen |
| N-0319 Oslo |

GlaxoSmithKline AS

Forskningsveien 2a

Postbox 180 Vinderen

N-0319 Oslo

Lamictal

2 mg

Dispersible tablet

Oral use

Norway

| GlaxoSmithKline AS |
| --- |
| Forskningsveien 2a |
| Postbox 180 Vinderen |
| N-0319 Oslo |

GlaxoSmithKline AS

Forskningsveien 2a

Postbox 180 Vinderen

N-0319 Oslo

Lamictal

5 mg

Dispersible tablet

Oral use

Norway

| GlaxoSmithKline AS |
| --- |
| Forskningsveien 2a |
| Postbox 180 Vinderen |
| N-0319 Oslo |

GlaxoSmithKline AS

Forskningsveien 2a

Postbox 180 Vinderen

N-0319 Oslo

Lamictal

25 mg

Dispersible tablet

Oral use

Norway

| GlaxoSmithKline AS |
| --- |
| Forskningsveien 2a |
| Postbox 180 Vinderen |
| N-0319 Oslo |

GlaxoSmithKline AS

Forskningsveien 2a

Postbox 180 Vinderen

N-0319 Oslo

Lamictal

50 mg

Dispersible tablet

Oral use

Norway

| GlaxoSmithKline AS |
| --- |
| Forskningsveien 2a |
| Postbox 180 Vinderen |
| N-0319 Oslo |

GlaxoSmithKline AS

Forskningsveien 2a

Postbox 180 Vinderen

N-0319 Oslo

Lamictal

100 mg

Dispersible tablet

Oral use

Norway

| GlaxoSmithKline AS |
| --- |
| Forskningsveien 2a |
| Postbox 180 Vinderen |
| N-0319 Oslo |

GlaxoSmithKline AS

Forskningsveien 2a

Postbox 180 Vinderen

N-0319 Oslo

Lamictal

200 mg

Dispersible tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin

25 mg

Tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin

50 mg

Tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin

100 mg

Tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin S

2 mg

Dispersible tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin S

5 mg

Dispersible tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin S

25 mg

Dispersible tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin S

50 mg

Dispersible tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin S

100 mg

Dispersible tablet

Oral use

Poland

| GlaxoSmithKline Export Ltd |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

GlaxoSmithKline Export Ltd

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

Lamitrin S

200 mg

Dispersible tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

25 mg

Tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

50 mg

Tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

100 mg

Tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

200 mg

Tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

2 mg

Dispersible tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

5 mg

Dispersible tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

25 mg

Dispersible tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

50 mg

Dispersible tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

100 mg

Dispersible tablet

Oral use

Portugal

| Laboratórios Wellcome de Portugal Lda. |
| --- |
| Rua Dr. António Loureiro Borges n.o 3 |
| Arquiparque-Miraflores |
| P-1495-131 Algés |

Laboratórios Wellcome de Portugal Lda.

Rua Dr. António Loureiro Borges n.o 3

Arquiparque-Miraflores

P-1495-131 Algés

Lamictal

200 mg

Dispersible tablet

Oral use

Romania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 25 mg

25 mg

Tablet

Oral use

Romania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 50 mg

50 mg

Tablet

Oral use

Romania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 100 mg

100 mg

Tablet

Oral use

Romania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 2 mg

2 mg

Dispersible/Chewable tablet

Oral use

Romania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 5 mg

5 mg

Dispersible/Chewable tablet

Oral use

Romania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 25 mg

25 mg

Dispersible/Chewable tablet

Oral use

Romania

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

Lamictal 100 mg

100 mg

Dispersible/Chewable tablet

Oral use

Slovakia

| GlaxoSmithKline Slovakia s.r.o. |
| --- |
| Galvaniho 7/A |
| SK-82104 Bratislava |

GlaxoSmithKline Slovakia s.r.o.

Galvaniho 7/A

SK-82104 Bratislava

Lamictal 25 mg

25 mg

Tablet

Oral use

Slovakia

| GlaxoSmithKline Slovakia s.r.o. |
| --- |
| Galvaniho 7/A |
| SK-82104 Bratislava |

GlaxoSmithKline Slovakia s.r.o.

Galvaniho 7/A

SK-82104 Bratislava

Lamictal 50 mg

50 mg

Tablet

Oral use

Slovakia

| GlaxoSmithKline Slovakia s.r.o. |
| --- |
| Galvaniho 7/A |
| SK-82104 Bratislava |

GlaxoSmithKline Slovakia s.r.o.

Galvaniho 7/A

SK-82104 Bratislava

Lamictal 100 mg

100 mg

Tablet

Oral use

Slovakia

| GlaxoSmithKline Slovakia s.r.o. |
| --- |
| Galvaniho 7/A |
| SK-82104 Bratislava |

GlaxoSmithKline Slovakia s.r.o.

Galvaniho 7/A

SK-82104 Bratislava

Lamictal 2 mg

2 mg

Dispersible tablet

Oral use

Slovakia

| GlaxoSmithKline Slovakia s.r.o. |
| --- |
| Galvaniho 7/A |
| SK-82104 Bratislava |

GlaxoSmithKline Slovakia s.r.o.

Galvaniho 7/A

SK-82104 Bratislava

Lamictal 5 mg

5 mg

Dispersible tablet

Oral use

Slovakia

| GlaxoSmithKline Slovakia s.r.o. |
| --- |
| Galvaniho 7/A |
| SK-82104 Bratislava |

GlaxoSmithKline Slovakia s.r.o.

Galvaniho 7/A

SK-82104 Bratislava

Lamictal 25 mg

25 mg

Dispersible tablet

Oral use

Slovakia

| GlaxoSmithKline Slovakia s.r.o. |
| --- |
| Galvaniho 7/A |
| SK-82104 Bratislava |

GlaxoSmithKline Slovakia s.r.o.

Galvaniho 7/A

SK-82104 Bratislava

Lamictal 100 mg

100 mg

Dispersible tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 25 mg tablete

25 mg

Tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 50 mg tablete

50 mg

Tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 100 mg tablete

100 mg

Tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 200 mg tablete

200 mg

Tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 5 mg disperzibilne/žvečljive tablete

5 mg

Dispersible/Chewable tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 25 mg disperzibilne/žvečljive tablete

25 mg

Dispersible/Chewable tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 50 mg disperzibilne/žvečljive tablete

50 mg

Dispersible/Chewable tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 100 mg disperzibilne/žvečljive tablete

100 mg

Dispersible/Chewable tablet

Oral use

Slovenia

| GSK d.o.o. |
| --- |
| Knezov štradon 90 |
| SLO-1000 Ljubljana |

GSK d.o.o.

Knezov štradon 90

SLO-1000 Ljubljana

Lamictal 200 mg disperzibilne/žvečljive tablete

200 mg

Dispersible/Chewable tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

50 mg

Tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

100 mg

Tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

200 mg

Tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

2 mg

Dispersible tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

5 mg

Dispersible tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

25 mg

Dispersible tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

50 mg

Dispersible tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

100 mg

Dispersible tablet

Oral use

Spain

| GlaxoSmithKline SA |
| --- |
| Severo Ochoa no 2 |
| E-28760 Tres Cantos Madrid |

GlaxoSmithKline SA

Severo Ochoa no 2

E-28760 Tres Cantos Madrid

Lamictal

200 mg

Dispersible tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

25 mg

Tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

50 mg

Tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

100 mg

Tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

200 mg

Tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

2 mg

Soluble tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

5 mg

Soluble tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

25 mg

Soluble tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

50 mg

Soluble tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

100 mg

Soluble tablet

Oral use

Sweden

| GlaxoSmithKline AB |
| --- |
| Box 516 |
| S-169 29 Solna |

GlaxoSmithKline AB

Box 516

S-169 29 Solna

Lamictal

200 mg

Soluble tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

25 mg

Tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

50 mg

Tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

100 mg

Tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

200 mg

Tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

2 mg

Dispersible tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

5 mg

Dispersible tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

25 mg

Dispersible tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

50 mg

Dispersible tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

100 mg

Dispersible tablet

Oral use

United Kingdom

| The Wellcome Foundation Limited |
| --- |
| Glaxo Wellcome House |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

The Wellcome Foundation Limited

Glaxo Wellcome House

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

| Trading as |
| --- |
| GlaxoSmithKline UK |
| Stockley Park West |
| Uxbridge |
| Middlesex UB11 1BT |
| United Kingdom |

Trading as

GlaxoSmithKline UK

Stockley Park West

Uxbridge

Middlesex UB11 1BT

United Kingdom

Lamictal

200 mg

Dispersible tablet

Oral use

---

NOTICES FROM MEMBER STATES

| 29.8.2008 | EN | Official Journal of the European Union | C 220/63 |
| --- | --- | --- | --- |

29.8.2008

EN

Official Journal of the European Union

C 220/63

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises

(Text with EEA relevance)

(2008/C 220/05)

| Aid No | XS 136/08 |
| --- | --- |
| Member State | Poland |
| Region | Mazowieckie |
| Title of aid scheme or name of company receiving individual aid | Przedsiębiorstwo techniczno handlowe Certech Jan Kuca, Jerzy Motyka Sp. z. o.o. |
| Legal basis | Ustawa z dnia 8 października 2004 r. o zasadach finansowania nauki art. 10, Rozporządzenie Ministra Nauki i Szkolnictwa Wyższego, (Dz.U. 221 z 14.11.2007 r.), § 3 ust. 1, umowa nr II-191/P-226/2008 |
| Type of measure | Ad hoc |
| Budget | Overall budget: EUR 74 680 |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation |
| Date of implementation | 2.4.2008 |
| Duration | 2.4.2008 |
| Objective | Small and medium-sized enterprises |
| Economic sectors | All sectors eligible for aid to SMEs |
| Name and address of the granting authority | Ministerstwo Nauki i Szkolnictwa Wyższego |
| Ul. Wspólna 1/3 |
| PL-00-529 Warszawa |

Aid No

XS 136/08

Member State

Poland

Region

Mazowieckie

Title of aid scheme or name of company receiving individual aid

Przedsiębiorstwo techniczno handlowe Certech Jan Kuca, Jerzy Motyka Sp. z. o.o.

Legal basis

Ustawa z dnia 8 października 2004 r. o zasadach finansowania nauki art. 10, Rozporządzenie Ministra Nauki i Szkolnictwa Wyższego, (Dz.U. 221 z 14.11.2007 r.), § 3 ust. 1, umowa nr II-191/P-226/2008

Type of measure

Ad hoc

Budget

Overall budget: EUR 74 680

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Date of implementation

2.4.2008

Duration

2.4.2008

Objective

Small and medium-sized enterprises

Economic sectors

All sectors eligible for aid to SMEs

Name and address of the granting authority

Ministerstwo Nauki i Szkolnictwa Wyższego

Ul. Wspólna 1/3

PL-00-529 Warszawa

| Aid No | XS 145/08 |
| --- | --- |
| Member State | Estonia |
| Region | — |
| Title of aid scheme or name of company receiving individual aid | Teadus- ja arendustegevuse projektide toetamine |
| Legal basis | Majandus- ja kommunikatsiooniministri 15. mai 2008. a määrus nr 40 „Teadus- ja arendustegevuse projektide toetamise tingimused ja kord” (RTL, 22.05.2008, 40, 560)
  https://www.riigiteataja.ee/ert/act.jsp?id=12962956 |
| Type of measure | Aid scheme |
| Budget | Annual budget: EUR 15 million |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation |
| Date of implementation | 25.5.2008 |
| Duration | 31.12.2013 |
| Objective | Small and medium-sized enterprises |
| Economic sectors | All manufacturing, Processing and marketing of agricultural products, All services |
| Name and address of the granting authority | Ettevõtluse Arendamise Sihtasutus |
| Liivalaia 13/15 |
| EE-10118 Tallinn |

Aid No

XS 145/08

Member State

Estonia

Region

—

Title of aid scheme or name of company receiving individual aid

Teadus- ja arendustegevuse projektide toetamine

Legal basis

Majandus- ja kommunikatsiooniministri 15. mai 2008. a määrus nr 40 „Teadus- ja arendustegevuse projektide toetamise tingimused ja kord” (RTL, 22.05.2008, 40, 560)

https://www.riigiteataja.ee/ert/act.jsp?id=12962956

Type of measure

Aid scheme

Budget

Annual budget: EUR 15 million

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Date of implementation

25.5.2008

Duration

31.12.2013

Objective

Small and medium-sized enterprises

Economic sectors

All manufacturing, Processing and marketing of agricultural products, All services

Name and address of the granting authority

Ettevõtluse Arendamise Sihtasutus

Liivalaia 13/15

EE-10118 Tallinn

| Aid No | XS 147/08 |
| --- | --- |
| Member State | Lithuania |
| Region | — |
| Title of aid scheme or name of company receiving individual aid | Priemone „Idėja LT“ |
| Legal basis | 2008 m. birželio 13 d. įsakymas Nr. 4-247 „Dėl priemones „Idėja LT“ projektu finansavimo sąlygų aprašo patvirtinimo“ (Žin., 2008, Nr. 70-2668) |
| Type of measure | Aid scheme |
| Budget | Annual budget: LTL 20 million |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation |
| Date of implementation | 19.6.2008 |
| Duration | 31.12.2008 |
| Objective | Small and medium-sized enterprises |
| Economic sectors | All sectors eligible for aid to SMEs |
| Name and address of the granting authority | Lietuvos Respublikos ūkio ministerija |
| Gedimino pr. 38/2 |
| LT-01104 Vilnius |
| Tel. (370-5) 262 38 63 |
| kanc@ukmin.lt |

Aid No

XS 147/08

Member State

Lithuania

Region

—

Title of aid scheme or name of company receiving individual aid

Priemone „Idėja LT“

Legal basis

2008 m. birželio 13 d. įsakymas Nr. 4-247 „Dėl priemones „Idėja LT“ projektu finansavimo sąlygų aprašo patvirtinimo“ (Žin., 2008, Nr. 70-2668)

Type of measure

Aid scheme

Budget

Annual budget: LTL 20 million

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Date of implementation

19.6.2008

Duration

31.12.2008

Objective

Small and medium-sized enterprises

Economic sectors

All sectors eligible for aid to SMEs

Name and address of the granting authority

Lietuvos Respublikos ūkio ministerija

Gedimino pr. 38/2

LT-01104 Vilnius

Tel. (370-5) 262 38 63

kanc@ukmin.lt

| Aid No | XS 151/08 |
| --- | --- |
| Member State | Spain |
| Region | La Rioja |
| Title of aid scheme or name of company receiving individual aid | Bases reguladoras de la concesión de subvenciones a la inversión destinadas a pymes del sector industrial, comercio mayorista y de servicios |
| Legal basis | Orden no 7/2008 de 3 de junio de 2008, de la Consejería de Industria, Innovación y Empleo, por la que se aprueban las Bases reguladoras de la concesión de subvenciones por la Agencia de Desarrollo Económico de La Rioja a la inversión destinadas a pymes del sector industrial, comercio mayorista y de servicios, en régimen de concurrencia competitiva (B.O.R. no 75/2008, de 7 de junio) |
| Type of measure | Aid scheme |
| Budget | Annual budget: EUR 4,45 million |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation |
| Date of implementation | 7.6.2008 |
| Duration | 31.12.2013 |
| Objective | Small and medium-sized enterprises |
| Economic sectors | All sectors eligible for aid to SMEs |
| Name and address of the granting authority | Agencia de Desarrollo Económico de La Rioja |
| C/ Muro de la Mata no 13-14 |
| E-26071 Logroño (La Rioja) |

Aid No

XS 151/08

Member State

Spain

Region

La Rioja

Title of aid scheme or name of company receiving individual aid

Bases reguladoras de la concesión de subvenciones a la inversión destinadas a pymes del sector industrial, comercio mayorista y de servicios

Legal basis

Orden no 7/2008 de 3 de junio de 2008, de la Consejería de Industria, Innovación y Empleo, por la que se aprueban las Bases reguladoras de la concesión de subvenciones por la Agencia de Desarrollo Económico de La Rioja a la inversión destinadas a pymes del sector industrial, comercio mayorista y de servicios, en régimen de concurrencia competitiva (B.O.R. no 75/2008, de 7 de junio)

Type of measure

Aid scheme

Budget

Annual budget: EUR 4,45 million

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Date of implementation

7.6.2008

Duration

31.12.2013

Objective

Small and medium-sized enterprises

Economic sectors

All sectors eligible for aid to SMEs

Name and address of the granting authority

Agencia de Desarrollo Económico de La Rioja

C/ Muro de la Mata no 13-14

E-26071 Logroño (La Rioja)

Dirección Internet publicación régimen de ayuda:

http://www.larioja.org/npRioja/default/defaultpage.jsp?idtab=449883

| Aid No | XS 155/08 |
| --- | --- |
| Member State | Germany |
| Region | Freie und Hansestadt Hamburg |
| Title of aid scheme or name of company receiving individual aid | Firma High Fly Reisen |
| Karolinenstraße 6 |
| D-20357 Hamburg |

Aid No

XS 155/08

Member State

Germany

Region

Freie und Hansestadt Hamburg

Title of aid scheme or name of company receiving individual aid

Firma High Fly Reisen

Karolinenstraße 6

D-20357 Hamburg

Legal basis

Verordnung (EG) Nr. 70/2001 der Kommission vom 12. Januar 2001 über die Anwendung der Artikel 87 und 88 des EG-Vertrags auf staatliche Beihilfen an kleine und mittlere Unternehmen (ABl. L 10 vom 13.1.2001, S. 33 verlängert durch ABl. L 368 vom 23.12.2006, S. 85); Gesetz über die Kreditkommission vom 29.4.1997 (Hamburgisches Gesetz- und Verordnungsblatt 1997, Nr. 18, Seite 133)

Type of measure

Individual aid

Budget

Overall budget: EUR 4 000

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Date of implementation

29.5.2008

Duration

29.11.2008

Objective

Small and medium-sized enterprises

Economic sectors

Other services

Name and address of the granting authority

| Behörde für Wirtschaft und Arbeit |
| --- |
| Alter Steinweg 4 |
| D-20459 Hamburg |

Behörde für Wirtschaft und Arbeit

Alter Steinweg 4

D-20459 Hamburg

---

| 29.8.2008 | EN | Official Journal of the European Union | C 220/66 |
| --- | --- | --- | --- |

29.8.2008

EN

Official Journal of the European Union

C 220/66

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 68/2001 on the application of Articles 87 and 88 of the EC Treaty to training aid

(Text with EEA relevance)

(2008/C 220/06)

| Reference number of the aid | XT 70/08 |
| --- | --- |
| Member State | Portugal |
| Region | Todas as NUTS II de Portugal: Norte, Centro, Lisboa, Alentejo, Algarve, Região Autónoma dos Açores, Região Autónoma da Madeira |
| Title (and/or name of the beneficiary) | SI Inovação
  SI PME |
| Legal basis | Endereço do regime notificado
  http://www.pofc.qren.pt/ResourcesUser/Legislacao/Apoios_FormacaoProfissional.pdf
  (Está em curso a correcção do artigo 14.o do Regulamento notificado, substituindo «... regulamento referido no artigo 17.o, ...» para «... regulamento referido no artigo 18.o, ...»)
  SI Inovação — Portaria n.o 1464/2007
  Endereço
  http://www.pofc.qren.pt/ResourcesUser/Legislacao/P1464_07.pdf
  SI PME — Portaria n.o 1463/2007
  Endereço
  http://www.pofc.qren.pt/ResourcesUser/Legislacao/Portaria1463_07.pdf |
| Type of measure | Aid scheme |
| Budget | Annual budget: EUR 200 million |
| Maximum aid intensity | In conformity with Article 4(2)-(7) of the Regulation |
| Date of implementation | 5.2.2008 |
| Duration | 31.12.2013 |
| Objective | General training; Specific training |
| Economic sectors | Motor vehicles, Other manufacturing, Other transport services, Other services |
| Name and address of the granting authority | Programa Operacional Temático Factores de Competitividade (www.pofc.qren.pt)
  Programa Operacional Regional do Norte (www.ccdr-n.pt/novonorte)
  Programa Operacional Regional do Centro (http://www.ccdrc.pt/po-centro-2007-2013)
  Programa Operacional Regional de Lisboa (www.porlisboa.qren.pt)
  Programa Operacional Regional do Alentejo (www.ccdr-a.gov.pt/poaqren/)
  Programa Operacional Regional do Algarve (www.ccdr-alg.pt)
  Programa Operacional Regional da Madeira (www.idr.gov-madeira.pt/pt/legis_intervir.asp)
  Programa Operacional Regional dos Açores (www.proconvergencia.azores.gov.pt) |

Reference number of the aid

XT 70/08

Member State

Portugal

Region

Todas as NUTS II de Portugal: Norte, Centro, Lisboa, Alentejo, Algarve, Região Autónoma dos Açores, Região Autónoma da Madeira

Title (and/or name of the beneficiary)

SI Inovação

SI PME

Legal basis

Endereço do regime notificado

http://www.pofc.qren.pt/ResourcesUser/Legislacao/Apoios_FormacaoProfissional.pdf

(Está em curso a correcção do artigo 14.o do Regulamento notificado, substituindo «... regulamento referido no artigo 17.o, ...» para «... regulamento referido no artigo 18.o, ...»)

SI Inovação — Portaria n.o 1464/2007

Endereço

http://www.pofc.qren.pt/ResourcesUser/Legislacao/P1464_07.pdf

SI PME — Portaria n.o 1463/2007

Endereço

http://www.pofc.qren.pt/ResourcesUser/Legislacao/Portaria1463_07.pdf

Type of measure

Aid scheme

Budget

Annual budget: EUR 200 million

Maximum aid intensity

In conformity with Article 4(2)-(7) of the Regulation

Date of implementation

5.2.2008

Duration

31.12.2013

Objective

General training; Specific training

Economic sectors

Motor vehicles, Other manufacturing, Other transport services, Other services

Name and address of the granting authority

Programa Operacional Temático Factores de Competitividade (www.pofc.qren.pt)

Programa Operacional Regional do Norte (www.ccdr-n.pt/novonorte)

Programa Operacional Regional do Centro (http://www.ccdrc.pt/po-centro-2007-2013)

Programa Operacional Regional de Lisboa (www.porlisboa.qren.pt)

Programa Operacional Regional do Alentejo (www.ccdr-a.gov.pt/poaqren/)

Programa Operacional Regional do Algarve (www.ccdr-alg.pt)

Programa Operacional Regional da Madeira (www.idr.gov-madeira.pt/pt/legis_intervir.asp)

Programa Operacional Regional dos Açores (www.proconvergencia.azores.gov.pt)

| Reference number of the aid | XT 71/08 |
| --- | --- |
| Member State | Sweden |
| Region | — |
| Title (and/or name of the beneficiary) | Stöd till insatser på livsmedelsområdet |
| Legal basis | 8 § förordningen (2008:80) om stöd till insatser på livsmedelsområdet |
| Type of measure | Aid scheme |
| Budget | Annual budget: SEK 21,48 million |
| Maximum aid intensity | In conformity with Article 4(2)-(7) of the Regulation |
| Date of implementation | 1.5.2008 |
| Duration | 31.12.2010 |
| Objective | General training |
| Economic sectors | Other manufacturing |
| Name and address of the granting authority | Statens jordbruksverk |
| S-551 82 Jönköping |

Reference number of the aid

XT 71/08

Member State

Sweden

Region

—

Title (and/or name of the beneficiary)

Stöd till insatser på livsmedelsområdet

Legal basis

8 § förordningen (2008:80) om stöd till insatser på livsmedelsområdet

Type of measure

Aid scheme

Budget

Annual budget: SEK 21,48 million

Maximum aid intensity

In conformity with Article 4(2)-(7) of the Regulation

Date of implementation

1.5.2008

Duration

31.12.2010

Objective

General training

Economic sectors

Other manufacturing

Name and address of the granting authority

Statens jordbruksverk

S-551 82 Jönköping

| Reference number of the aid | XT 72/08 |
| --- | --- |
| Member State | Italy |
| Region | Provincia autonoma di Trento |
| Title (and/or name of the beneficiary) | Finanziamento di iniziative formative a favore dei lavoratori delle imprese riferibili alla gestione dei fondi di cui all'art. 9, comma 3, della legge 19 luglio 1993, n. 236 per l'anno 2008 — D. D. del ministero del Lavoro e della previdenza sociale 40/Cont/V/2007 |
| Legal basis | Deliberazione della Giunta provinciale n. 1260 di data 23.5.2008 pubblicata sul Bollettino della Regione Trentino Alto Adige n. 23 di data 3.6.2008 |
| Type of measure | Aid scheme |
| Budget | Annual budget: EUR 1,70 million |
| Maximum aid intensity | In conformity with Article 4(2)-(7) of the Regulation |
| Date of implementation | 3.6.2008 |
| Duration | 30.6.2008 |
| Objective | Specific training |
| Economic sectors | All sectors eligible for training aid |
| Name and address of the granting authority | Provincia autonoma di Trento |
| Via Zambra, 42 |
| I-38100 Trento |

Reference number of the aid

XT 72/08

Member State

Italy

Region

Provincia autonoma di Trento

Title (and/or name of the beneficiary)

Finanziamento di iniziative formative a favore dei lavoratori delle imprese riferibili alla gestione dei fondi di cui all'art. 9, comma 3, della legge 19 luglio 1993, n. 236 per l'anno 2008 — D. D. del ministero del Lavoro e della previdenza sociale 40/Cont/V/2007

Legal basis

Deliberazione della Giunta provinciale n. 1260 di data 23.5.2008 pubblicata sul Bollettino della Regione Trentino Alto Adige n. 23 di data 3.6.2008

Type of measure

Aid scheme

Budget

Annual budget: EUR 1,70 million

Maximum aid intensity

In conformity with Article 4(2)-(7) of the Regulation

Date of implementation

3.6.2008

Duration

30.6.2008

Objective

Specific training

Economic sectors

All sectors eligible for training aid

Name and address of the granting authority

Provincia autonoma di Trento

Via Zambra, 42

I-38100 Trento

---